Skip to main content
ASPHO Logo
Menu Journal My Account Contact Join/Renew
Login
  • Meetings & Events
    • Conference
      • 2023 Conference
        • 2023 Conference
        • Hotel and Travel
        • Health and Safety
        • Registration
        • Schedule
        • Continuing Education
        • Corporate Symposia
        • Commercial Support
          • Virtual Exhibitor and Engagement Opportunities
        • Back to Meetings
      • Meetings Archive
      • Press | 2018 Conference
      • 2018 Call for Papers and Posters
        • Back to Meetings
        • 2019 Conference
        • Schedule of Events
        • Registration Rates
        • Conference Planning Committee
        • Conference Hotel and Travel
        • Faculty
        • 2019 Call for Papers and Posters
        • Continuing Education
        • PBMTC
        • Accepted Papers and Posters
        • Corporate Symposia
        • MOC Opportunities
        • App - Thank you for Attending
        • 2019 Attendee List
      • 2019 Call for Workshops
      • 2018 Conference
        • Schedule of Events
        • Accepted Papers and Posters
      • 2016 Annual Meeting
        • Overview
        • Attendee List
        • ASPHO Virtual Bag
        • Corporate Forum Symposia/Education Theaters
        • Accepted Papers and Posters
          • Accepted A-G
          • Accepted H-M
          • Accepted N-Z
          • 2016 Searchable Abstract Database
        • Exhibit Hall
        • Sponsors
        • Annual Meeting Brochure
        • 2017 Call for Workshops
        • Virtual Bag
        • Schedule of Events
        • Continuing Education
        • Attendee List
        • 2017 Searchable Abstract Database
        • Accepted Papers and Posters
        • Corporate Forum Symposia/Education Theater
        • Travel
        • Program Committee
        • Commercial Support
        • Exhibit with ASPHO
    • Review Course
      • 2023 Review Course
        • Review Course 2023 Cancellation Policies and Disclosures
      • Anderson 2019
      • McClain 2019
      • Adams 2019
      • Moran 2019
      • Effinger 2019
      • Fangusaro 2021
      • Brown 2021
      • Young 2021
      • Harker-Murray 2021
      • Effinger 2021
      • Pai 2021
      • Grace 2021
      • Rogers 2021
      • Anderson 2021
      • Powers 2021
      • McClain 2021
      • Neunert 2021
      • Fleming 2021
      • Mullen 2021
      • Pommert 2021
      • Meade 2021
      • Greengard 2021
      • Fox 2021
      • Bercovitz 2021
      • Brock 2021
      • Adams 2021
      • Loh 2021
      • O'Brien 2021
      • Walterhouse 2021
      • Pulsipher 2021
      • Oberley 2021
      • Rodriguez-Galindo 2021
      • Kesselheim 2021
      • Frei-Jones 2021
      • Allen 2021
      • 2015 Online Review Course CME Certificates
      • 2019 Planning Committee
      • 2019 Schedule
      • 2019 Travel
      • 2019 Review Course Early Career
      • 2019 Review Course Directors
        • 2019 Review Course Faculty
      • Oberley 2019
      • O'Brien 2019
      • Pai 2019
      • Pulsipher 2019
      • Rodriguez-Galindo 2019
      • Rogers 2019
      • Walterhouse 2019
      • Young 2019
      • Park 2019
      • Malec 2019
      • Evaluations
      • Brown 2019
      • Allen 2019
      • Fangusaro 2019
      • Fleming 2019
      • Frei-Jones 2019
      • Grace 2019
      • Harker-Murray 2019
      • Heeney 2019
      • Kesselheim 2019
      • Loh 2019
      • Mascarenhas 2019
      • Neunert 2019
      • Fangusaro 2023
      • Adams 2023
      • Neunert 2023
      • Oberley 2023
      • Grace 2023
      • Effinger 2023
      • Nakano 2023
      • Brock 2023
      • Harker-Murray 2023
      • Meade 2023
      • Fleming 2023
      • Kesselheim
      • Kumar 2023
      • Anderson 2023
      • Malogolowkin 2023
      • Pommert 2023
      • Bercovitz 2023
      • Frei-Jones 2023
      • O'Brien 2023
      • Pai 2023
      • Young 2023
      • Fox 2023
      • Powers 2023
      • Pulsipher 2023
      • McClain 2023
      • Loh 2023
      • Greengard 2023
      • Frazier 2023
      • Brennan 2023
      • Walkovich 2023
      • Browning 2023
      • 2023 Faculty
        • Office Hours
        • Learning Objectives and CME
        • Faculty
        • Planning Committee
      • Mullen 2023
      • 2023 Schedule
      • 2023 Learning Objectives and CME
      • Review Course Archive
    • Events Calendar
  • Knowledge Center
    • Products
      • KARE Toolkit: Knowledge and Assessment Resources
        • CME for KARE
        • CME for RC On-Demand
        • CME for PHO Review Course On Demand
        • CME for KARE Plus
        • CME for KARE Plus Hematology
        • CME for KARE Plus Oncology
        • The KARE Toolkit - Index of Topics
      • Recordings
      • Webinars
      • ASPHOcast
      • 2020 Compensation Survey
    • Online Review Course
    • Pediatric Blood & Cancer
      • Access Journal
      • Online Access Instructions
    • ASPHO eNews
      • August 2015 Enews
      • June 2015 Enews
      • April 2015 Enews
      • February 2015 Enews
      • December 2014 Enews
      • October 2014 Enews
      • August 2014 Enews
      • June 2014 Enews
      • April 2014 Enews
      • February 2014 Enews
      • December 2013 Enews
      • October 2013 Enews
      • August 2013 Enews
      • June 2013 Enews
      • April 2013 Enews
      • February 2013 Enews
      • October 2014 Enews
      • October 2015 Enews
      • December 2015 Enews
      • February 2016 Enews
      • April 2016 Enews
      • June 2016 Enews
        • DSIG Student Registration
      • August 2016 Enews
      • October 2016 Enews
      • December 2016 Enews
      • February 2017 Enews
      • April 2017 Enews
      • June 2017 Enews
      • August 2017 Enews
      • October 2017 Enews
      • December 2017 Enews
      • February 2018 Enews
      • April 2018 Enews
      • June 2018 Enews
      • August 2018 eNews
      • October 2018 eNews
      • February 2019 eNews
      • Member Insights: eNews 2018 Highlights
      • April 2019 eNews
      • June 2019 eNews
      • August 2019 eNews
      • October 2019 eNews
      • December 2019 eNews
      • February 2020 eNews
      • April 2020 eNews
      • June 2020 eNews
      • August 2020 eNews
      • October 2020 eNews
      • December 2020 eNews
      • April 2021 eNews
      • June 2021 eNews
      • August 2021 eNews
        • August 2021 President's Message
      • December 2021 eNews
      • February 2022 eNews
      • April 2022 eNews
      • June 2022 eNews
      • August 2022 eNews
      • October 2022 eNews
      • December 2022 eNews
      • February 2023 eNews
    • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
    • October 2015 Enews
    • Advocacy Sample
    • News Briefs
    • Health Policy & Advocacy
      • 2016 August Advocacy Brief
      • 2016 December Advocacy Brief
      • 2017 February Advocacy Brief
      • 2017 May Advocacy Brief
      • 2017 September Advocacy Brief
      • 2017 November Advocacy Brief
      • 2018 Advocacy Brief - March
      • Contact Your Members of Congress
      • 2018-Advocacy-Brief-June
      • 2018-Advocacy-Brief-September
      • Advocacy Brief December 2018
      • 2019 Advocacy Brief - March
      • March 2019 Advocacy Brief
      • June 2019 Advocacy Brief
      • September 2019 Advocacy Brief
      • March 2020 Advocacy Brief
      • June 2020 Advocacy Brief
      • September 2020 Advocacy Brief
      • December 2020 Advocacy Brief
      • June 2021 Advocacy Brief
      • September 2021 Advocacy Brief
      • March 2022 Advocacy Brief
      • June 2022 Advocacy Brief
      • September 2022 Advocacy Brief
    • 2017 Workforce Survey Report
    • Help Fund the STAT Act
    • Practice and Quality
      • Choosing Wisely®
      • Position Paper
      • Endorsements
      • ASPHO Endorsements member only
  • Career Development
    • Mentoring
      • Early Career Mentoring
    • Awards
      • Distinguished Career Award
      • Oski Memorial Lectureship
      • International Travel Awards
      • Arceci Innovation Award
      • Buchanan Lectureship
      • Young Investigator Award
      • Young Investigator Form
      • EC Travel Stipend Form
      • Early Career Travel Stipend
      • Advanced Practice Provider Award
      • Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
    • Career Center
    • Fellowship Resources
      • Post-PHO Fellowship Program Directory
      • Fellowship Program Directors' Resources
    • Certification
      • Continuing Medical Education
      • advocating for moc
      • ABP MOC Letter Nov 2015
      • ABP Hematology/Oncology Content Outline
    • 2019 ASPHO Award Recipients
    • Workforce
  • Membership
    • Who Belongs
    • Benefits
    • Join Us
    • Renew
    • Membership Application
    • Fellows Group Application
    • Member Community
    • Find a Member
    • Special Interest Groups
      • Adolescent and Young Adult SIG
      • Advanced Practice Provider SIG
      • Cancer Predisposition SIG
      • Clinical Immunology SIG
      • Diversity SIG
        • 2017 DSIG Travel Award
      • Global Hem Onc SIG
      • Hemoglobinopathy SIG
      • Hospitalist Medicine SIG
      • Informatics, Innovation and Entrepreneurship SIG
      • Integrative Pediatric Hematology/Oncology SIG
      • Palliative Care SIG
      • Physician Scientist SIG
      • Quality Improvement and Patient Safety SIG
      • Small Program SIG
      • Vascular Anomalies SIG
      • Clinical Immunology SIG Webinar
      • Well-Being SIG
    • Enriching the Future
      • ETF Donors
      • ETF FAQ
      • ETF Programs
      • ETF Award Recipients
      • Donate
    • Stay Connected with ASPHO
    • New Member
    • Trainee Membership Level
    • Strengthen Your Everyday Practice
  • About
    • Governance
      • 2017 Election Nominations
      • 2019 Board and Nominating Committee members
      • Board of Trustees
      • Leadership Development & Election Process
      • Nominating FAQs
      • Strategic Plan
        • Leadership Domain
        • Education Domain
        • Career Domain
        • Administration Domain
      • Volunteer Opportunities
        • Early Career Council
    • Policies
      • Advertising Sponsorship
      • Support of CME
      • Committee Policies, Responsibilities, and Resources
      • Conflict of Interest and Disclosure for Volunteers
      • Distinguished Career Award Eligibility Criteria
      • Diversity Statement
      • Investment
      • Member Mailing List
      • Oski Eligibility Criteria
      • Presidential Stipend
      • Records Retention
      • Reserve Fund
      • Reviews and Endorsements
      • Speaker Reimbursement
      • Surveying Members
      • Whistleblower
      • Workshop Session
      • Young Investigator Award
      • Early Career Travel Stipend
      • Buchanan Lectureship Eligibility
      • ASPHO Statements
    • Terms of Use
    • Contact Us
    • 2016 Election Nominations
    • 2015 Election Candidates
    • FDA Approves Dinutuximab
    • Q&A Amy Billett
    • Fund Raising Policy
    • Support and Advertising
      • Exhibit
      • Advertising
      • Industry Relations Council
      • Grants
    • Diversity & Inclusion
    • Donate
  • 2017 Annual Meeting Session Recordings
  • 2018 Annual Meeting Session Recordings
  • George R. Buchanan Lectureship Award Presentation
  • Cancer Predispositions in Clinical Practice
  • Evidence and Equipoise in Pediatric Thrombosis - Updates from Randomized Controlled Trials
  • Playing on Our Strengths - Developing Interprofessional Teams in Pediatric Hematology-Oncology
  • Providing Optimal Pediatric Palliative Care: Overcoming the Barriers
  • When in Quebec, Do What the Quebecers Do (Part Deux) - It's All About Platelets!
  • Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for Pediatric Patients with ALL in the era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and 'MRD Status'
  • Award Presentations
  • Hemophilic Arthropathy, More Than Meets the Eye: Advances in Early Disease Detection from Clinical Tools to Musculoskeletal Imaging
  • ZFNs, CrispR/Cas9 and TALENS- Oh My!
  • Collaboration in the Treatment of Liver Tumors
  • Leukemia
  • Solid Tumors/Lymphoma
  • Hematology I
  • Beyond Antibodies and CAR T Cells: Challenges and Opportunities in Manipulating the Pediatric Cancer Immunome
  • Blood Clots in Sick Kids: A critical mini-review of venous thrombo-embolism in selected high-risk pediatric populations
  • It's not just about Diversity: Improving the Outcomes for All by Moving toward Equity
  • Children's Oncology Group (COG)
  • Outcomes Research
  • Social Media: The Good, The Bad, and Beyond
  • Sickle Cell Disease in the AYA population: Management Challenges for the Pediatric Hematologist
  • Molecularly Defined Rare Pediatric Sarcomas: An Update for the General Oncologist
  • Mechanisms of Tumor Microenvironment Immune Mediated Resistance and Methods of Therapeutic Circumvention
  • Behind the Scenes at Pediatric Blood & Cancer: Everything You Always Wanted to Know About Getting Published
  • New Insights in Inherited Hematologic Diseases
  • Changing Workforce of Pediatric Hematology/Oncology
  • New Diagnostic and Therapeutic Approaches of Opportunistic (Viral/Fungal) Infections in the Pediatric Cancer Patient
  • New Mutations and Targeted Therapies in Langerhans Cell Histiocytosis
  • Physician, Sustain Thyself: Building Resilience to Prevent Burnout
  • Practicing Precision in Pediatric Oncology: Three Perspectives
  • What's Happening in DC? A Look at ASPHO Advocacy Efforts
  • Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient
  • Brain Tumors
  • Hematology II
  • Sponsor, Exhibit, and Advertise
    • Exhibits
    • Advertising
    • Industry Relations Council
    • Exhibits Adveritising
  • Ward Testing OSE
  • 2018 Session | George R. Buchanan Lectureship Award Presentation
  • 2018 Session | Plenary Paper Session 2001-2002
  • 2018 Session | St. Baldrick's Foundation Robert J. Arceci Innovation Award Announcement
  • 2018 Session | Plenary Session—Health Care in the Current Political Climate: Stormy Days Ahead?
  • 2018 Session | Pediatric Ependymoma: The Science Driving Patient Care
  • 2018 Session | Iron: Let's Get Pumped
  • 2018 Session | Extracellular Vesicle Trafficking—Biology and Translational Impact in Hematology and Cancer
  • 2018 Session | Relapsed, Refractory, Metastatic Bone Sarcomas: New Insights on Pathogenesis, Prognosis and Treatment
  • 2018 Session | Alpha Thalassemia—A Growing Public Health Disease with Changing Landscape of In-Utero and Post-Natal Therapy
  • 2018 Session | Decision Making in Benign Hematology: Living in a World Without Randomized Trials
  • 2018 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
  • 2018 Session | Early Career Travel Stipend Awards
  • 2018 Session | Young Investigator Award Presentations
  • 2018 Session | Management of Extracranial Germ Cell Tumors in Adolescent and Young Adult Population
  • 2018 Session | Challenging Hematologic Complications Post–Stem Cell Transplantation and Beyond
  • 2018 Session | Advanced Symptom Management and End-of-Life Care: Multidisciplinary Primary Palliative Care for Pediatric Hematologists/Oncologists
  • 2018 Session | Paper Session - Solid Tumor
  • 2018 Session | Paper Session - Hematology
  • 2018 Session | Vascular Anomalies: The Great Mimickers
  • 2018 Session | Addressing Sexual Health in Adolescent and Young Adult Patients: What You Should Know as a Pediatric Hematology/Oncology Care Provider
  • 2018 Session | Navigating Intravascular Bottlenecks: A Critical Mini-Review of Pediatric Venous Thromboembolism in the Setting of an Anatomical Thrombophilia
  • 2018 Session | Paper Session - Children's Oncology Group (COG)
  • 2018 Session | Paper Session - Hematology Science
  • 2018 Session | Can Late Effects be Prevented in Pediatric Oncology?
  • 2018 Session | Clash of the Titans: Debates on Best Management of Patients with Bleeding Disorders
  • 2018 Session | Providing Effective Feedback: The Currency of Conflict Resolution
  • 2018 Session | Recent Advances and New Approaches to Rare Hematological Malignancies
  • 2018 Session | Primary and Secondary Stroke Prevention in Sickle Cell Disease: The Debate
  • 2018 Session | Combating an Unmet Need: Psychosocial Health
  • 2018 Session | Renal Tumors Beyond Wilms
  • 2018 Session | Pediatric and Neonatal Transfusion Medicine
  • 2018 Session | Mobile Applications in Clinical Practice
  • 2018 Session | Presidential Symposium—Partnering with Patients and Families to Improve Research and Clinical Decision-making
  • 2018 Session | Review of Rare Pediatric Head and Neck Tumors for the General Oncologist
  • 2018 Session | Emerging Therapies in Hemophilia
  • 2018 Session | How Should You Treat That Bug? A Debate About Antimicrobial Management in Fever and Neutropenia
  • 2018 Session | Paper Session with Luminary Investigator - Leukemia
  • 2018 Session | Paper Session with Luminary Investigator - Hematology
  • 2018 Session | Frank A. Oski Memorial Lectureship Award Presentation
  • December 2018 eNews
  • 2019 Session | Splenectomy - The Great Debate
  • 2019 Session | DICER1: Updates on Biology and Clinical Management
  • 2019 Session | Burnout in Pediatric Hematology/Oncology: Moving from Discussion to Action
  • 2019 Session | Diagnostic and Management Conundrums Surrounding Women with Heavy Menstrual Bleeding and Underlying Bleeding Disorders
  • 2019 Session | All That Glitters is Not Gold – How We Differentiate Primary HLH from Fake News
  • Models for International Pediatric Oncology Outreach
  • 2019 Session | Navigating Genetic Testing in the Pediatric Hematology Setting
  • 2019 Session | Radiation Therapy for Pediatric Cancer Patients: Updates and New Modalities
  • 2019 Session | The Microbiome: What Is It and Why Do We Care?
  • 2019 Session | Brain Attack: Therapeutic Advances in Neonatal and Childhood Stroke
  • 2019 Session | Advances in Pediatric AML
  • 2019 Session | Improving Medication Adherence for Adolescents and Young Adults: Is Technology the Answer?
  • 2019 Session | Metabolism in Pediatric Hematology/Oncology - Presidential Symposium
  • 2019 Session | Too Much of a Good Thing – Myeloproliferation in Children
  • 2019 Session | Multiple Bony Lytic Lesions, but Not Langerhans Cell Histiocytosis (LCH) – Now What?
  • 2019 Session | Savior Siblings: Medical, Ethical, and Psychosocial Considerations in using Preimplantation Genetic Diagnosis (PGD) to Ensure a Matched Sibling Donor for Hematopoietic Stem Cell Transplantation (HSCT)
  • 2019 Session | George R. Buchanan Lectureship Award Presentation
  • 2019 Session | 2019 St. Baldrick’s Foundation Robert J. Arceci Innovation Award Announcement and Past Recipient Presentation
  • 2019 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship Announcement and Frank A. Oski Memorial Lectureship Award Presentation
  • 2019 Session | New Paradigms for Severe Aplastic Anemia: Genetic Screening, Eltrombopag, and Up Front Unrelated Donor BMT
  • 2019 Session | Not Too Young for That Cancer: Adolescent and Young Adult Carcinomas
  • 2019 Session | Transforming the Treatment of Chronic Pain
  • 2019 Session | Putting an End to End Organ Damage in Sickle Cell Disease
  • 2019 Session | Defining Pediatric MDS: A Morphologic or Molecular Diagnosis?
  • 2019 Session | The Power of One: Present Challenges in Treating Rare Diseases
  • 2019 Session | Hematological Manifestations of Immune Deficiencies and Dysregulatory Disorders: When should you look harder for underlying causes of Autoimmune Cytopenias?
  • 2019 Session | Oncofertility Programs: More Than Just Sperm Banking
  • 2019 Session | The (Financial) Cost of a "Cure"
  • 2019 Session | (2001) Potential Utility of MRD to Identify Relapse in pALL Patients Treated with Tisagenlecleucel
  • 2019 Session | (2002) Lentiglobin Gene Therapy in Transfusion-Dependent Β-Thalassemia Patients with Non-β0/β0 Genotypes
  • 2019 Session | (2003) Mechanisms of Resistance to the Type II JAK2 Inhibitor CHZ868 in B-Cell Acute Lymphoblastic Leukemia
  • 2019 Session | (2004) Discovering Noncoding Genetic Elements that Regulate Globin Synthesis
  • 2019 Session | (2005) Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Safety & Efficacy
  • 2019 Session | (2006) Modeling IKZF1 Lesions in B-cell Acute Lymphoblastic Leukemia Reveals Potential Therapeutic Targets
  • 2019 Session | (2007) Prognostic Determinants in Childhood T-cell Acute Lymphoblastic leukemia: Results of DFCI 05001
  • 2019 Session | (2008) Gap Junction Interference increases Apoptosis in ALL cells and augments effects of Antimetabolites
  • 2019 Session | (2009) Hydroxyurea Lowers Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Anemia
  • 2019 Session | (2010) Novel Next-Generation Sequence based Assay for Non-Invasive Prenatal Testing of Sickle Cell Disease
  • 2019 Session | (2011) Gabapentin for Pain in Sickle Cell Disease: Results of a Randomized Phase II Clinical Trial
  • 2019 Session | (2012) Quality of Life is the most important Indication for Second-Line ITP Treatment in Children
  • 2019 Session | (2013) BCL2-Inhibitor Response in Neuroblastoma: Biomarkers and Therapy Resistance
  • 2019 Session | (2014) The Clinical Application of Molecular Testing in Pediatric Solid Tumors: An Institutional Experience
  • 2019 Session | (2015) Enhancing Tumor Directed T Cells with an Interleukin-7 Signal Modulator
  • 2019 Session | (2016) Epigenome Screening Identifies Transcriptional Elongation as Therapeutic Vulnerability in DIPG
  • 2019 Session | (2017) Levofloxacin Prophylaxis
  • 2019 Session | (2018) Renal Tumors: Future Roadmap
  • 2019 Session | (2019) Soft Tissue Sarcoma
  • 2019 Session | (2020) Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
  • 2019 Session | (2021) Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
  • 2019 Session | (2022) A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
  • 2019 Session | (2023) Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children
  • 2019 Session | The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
  • 2019 Session | (2024) Septic Shock (SS) Incidence in National ALL & AML Cohorts using Administrative & Clinical Trial Data
  • 2019 Session | (2025) Nelarabine Abrogates Relapse Rates in CNS-3 T-ALL: A Report from Children’s Oncology Group AALL0434
  • 2019 Session | (2026) Current Cancer Survivorship Practices: A Report from the Children’s Oncology Group (COG)
  • 2019 Session | (2027) Intra-Arterial Chemotherapy for Retinoblastoma: A 7-year Single Institution Experience
  • 2019 Session | Advancing Discovery in Hematology: Bench to Bedside? No. Bedside to Bench to Bedside...
  • 2019 Session | (2028) The Shwachman Diamond Syndrome Registry: Hematologic Complications
  • 2019 Session | (2029) Characteristics and Outcomes of Unprovoked Venous Thromboembolism in the Pediatric Population
  • 2019 Session | (2030) Third Party VST are an effective Therapy for the Treatment of BK-Virus Reactivation after Transplant
  • 2019 Session | (2031) Inhibition of Nemo-Like Kinase improves Erythropoiesis in Models of Diamond Blackfan Anemia
  • 2019 Annual Meeting Session Recordings
  • CI SIG Webinar
  • October 2021 eNews

The 2018 ASPHO Conference

May 2-5, 2018
Pittsburgh, PA
David L. Lawrence Convention Center

Accepted Papers and Posters

*Denotes selected as a platform session.

PDF of accepted abstracts | Poster Guidelines | Searchable Abstract Database | Pediatric Blood & Cancer Online Abstracts

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z

Joseph Abdul-Malak

316

 EFFECTS OF HYDROXYUREA ON PULMONARY HYPERTENSION IN SPLENECTOMIZED CHILDREN WITH SCD

Shirley Abraham

511

COMPARING GFR ESTIMATING EQUATIONS, 24-HOUR URINE AND MEASURED IOHEXOL GFR IN PEDIATRIC PATIENTS WITH CANCER

Denise Adams

414

PHASE II STUDY OF SIROLIMUS AND COMPLICATED VASCULAR ANOMALIES: LONG TERM OUTCOMES IN KAPOSIFORM HEMANGIOENDOTHELIOMA

Denise Adams

416

A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF SIROLIMUS AND BISPHOSPHONATES FOR THE TREATMENT OF GENERALIZED LYMPHATIC ANOMALY (GLA) AND GORHAM-STOUT DISEASE (GSD)

Denise Adams

424

CHARACTERIZATION OF LONG-TERM OUTCOMES FOR PEDIATRIC PATIENTS WITH EXTRAHEPATIC EPITHELIOID HEMANGIOMA

Olubunmi Afonja

429
BAY 81-8973 PROPHYLAXIS FREQUENCY AND PHARMACOKINETICS IN RELATION TO BLEEDING RATES IN PEDIATRIC PATIENTS: SUBANALYSIS OF LEOPOLD KIDS DATA  

Shreya Agarwal

051

RELAPSE OF T CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER MORE THAN TEN YEARS: TRUE RELAPSE OR SECOND MALIGNANCY?

Shreya Agarwal

082

TEENAGER WITH ATRAUMATIC COMPARTMENT SYNDROME: A RARE CASE OF ACQUIRED HEMOPHILIA A

Jennifer Agrusa

659

CHARACTERIZING PULMONARY DYSFUNCTION IN SURVIVORS OF CHILDHOOD HODGKIN LYMPHOMA

Maria Ahmad-Nabi

086
SUCCESSFUL IMMUNE TOLERANCE IN FACTOR IX DEFICIENCY PATIENTS WITH CYCLOPHOSPHAMIDE AND RITUXIMAB  

Maria Ahmad-Nabi

431

RISK FACTORS AND OUTCOMES OF DEEP VEIN THROMBOSIS IN PEDIATRIC OSTEOMYELITIS

Rafat Ahmed

358

FAT EMBOLISM SYNDROME IN SICKLE CELL SC DISEASE: A CASE PRESENTATION AND REVIEW

Sanjay Ahuja

419

EFFECTIVE PROPHYLAXIS WITH BAY 94-9027 IN ADOLESCENTS WITH HEMOPHILIA A: RESULTS FROM THE PROTECT VIII MAIN STUDY AND ONGOING EXTENSION

Hebah Al Absi

070
CONGENITALCOMBINED DEFICIENCY OF THE VITAMIN K-DEPENDENT CLOTTING FACTORS (VKCFD): A NOVEL HOMOZYGOUS MISSENSE GAMMA-GLUTAMYL CARBOXYLASE (GGCX) MUTATION  

Khalfan Al Senaidi

 202

DIASTOLIC DYSFUNCTION IN NON TRASNFUSED β THALASSAEMIA INTERMEDIA: CASE CONTROL STUDY

Neena Alex

334

THE ROLE OF FOLATE SUPPLEMENTATION IN IMPROVING CLINICAL OUTCOMES IN CHILDREN WITH SICKLE CELL DISEASE

Nesreen Ali

029

HEMOPHILIA AND CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

Jenna Allison

038
A CASE SERIES OF TWO UNIQUE CNS TUMOR DIAGNOSES PRESENTING AS LEPTOMENINGEAL DISEASE  

Warren Alperstein

099

A UNIQUE CASE OF BCOR+ UNDIFFERENTIATED SARCOMA- A NEW SUBTYPE OF SARCOMA

Warren Alperstein

006

AN EXTRA-RENAL WILMS' TUMOR PRESENTING AS A UTERINE MASS

Warren Alperstein

 920

STEROID DEPENDENT GRAFT-VERSUS-HOST-DISEASE MANAGED WITH WEEKLY BORTEZOMIB

Ali Amid

313
OPTIMIZING TRANSFUSION THERAPY FOR SURVIVORS OF HEMOGLOBIN BARTS HYDROPS FETALIS: DEFINING THE OPTIMAL TARGETS FOR HEMOGLOBIN H AND “FUNCTIONAL”  EMOGLOBIN LEVELS.  

Reuben Antony

654

PREGNANCY IN A YOUNG ADULT TREATED FOR ANAPLASTIC ASTROCYTOMA WITH RADIATION THERAPY AND BEVACIZUMAB

Claire Arbitre

357

EVALUATION OF VASO-OCCLUSIVE CRISIS MANAGEMENT WITH PATIENT CONTROLLED ANALGESIA IN CHILDREN WITH SICKLE CELL DISEASE REQUIRING ADMISSION

Paula Aristizabal

623

EDUCATING THE NEXT GENERATION: DEVELOPMENT AND IMPLEMENTATION OF A DELIVERY OF INFORMED CONSENT CURRICULUM FOR PEDIATRIC HEMATOLOGY/ONCOLOGY ELLOWS TO ENHANCE COMMUNICATION SKILLS

Paula Artistizabal

661
FACTORS AFFECTING COMPREHENSION AND VOLUNTARINESS DURING INFORMED CONSENT IN PEDIATRIC ONCOLOGY  

Amy Armstrong

504

NON-INVASIVE PATHOGEN DETECTION IN PEDIATRIC ONCOLOGY AND HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS AT RISK FOR DEEP FUNGAL INFECTIONS USING NEXT GENERATION SEQUENCING

Akua Asante

2028

PLATELET ONTOGENY: A CLOSER LOOK AT PLATELET IMMUNE FUNCTION*

Claire Atkinson

727

COMPLICATIONS ASSOCIATED WITH PLACING A PORT VERSUS AN EXTERNAL CATHETER DURING INDUCTION THERAPY IN CHILDREN DIAGNOSED WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Mark Atlas

639
GENETICS/GENOMICS CURRICULUM FOR PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWS  

Marie Claire Milady Auguste

740

EPIDEMIOLOGICAL PROFILE OF LYMPHOMAS MANAGED AT A PEDIATRIC HOSPITAL IN PORT-AU-PRINCE, HAITI, FROM JANUARY 2006 TO DECEMBER 2016

Waitman Aumann

2021

THE SIX1 HOMEOBOX GENE IS A NOVEL CRM1-DEPENDENT TARGET IN CALM-AF10 LEUKEMIAS*

Rakesh Awasthi

709

PHARMACOKINETICS AND PHARMACODYNAMICS OF TOCILIZUMAB FOR THE MANAGEMENT OF CYTOKINE RELEASE SYNDROME (CRS) IN PEDIATRIC AND YOUNG-ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) TREATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY TISAGENLECLEUCEL (CTL019)

Arahana Awasthi

750
POLATUZUMAB VEDOTIN (PV) ALONE OR IN-COMBINATION WITH OBINUTUZUMAB SIGNIFICANTLY ENHANCES IN-VITRO/IN-VIVO CYTOTOXICITY AGAINST BURKITT LYMPHOMA (BL) /PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA (PMBL)  

Jamie Aye

825

KINOMIC ALTERATIONS OF PRIMARY AND METASTATIC WILMS TUMOR BY FOCAL ADHESION KINASE INHIBITION

Asmaa Azab

346

A COMPARISON STUDY OF PULMONARY FUNCTION IN AMERICAN AND KUWITI CHILDREN WITH SICKLE CELL DISEASE

Priscila Badia

420

TOPICAL SIROLIMUS FOR CUTANEOUS MANIFESTATIONS OF VASCULAR MALFORMATIONS

Aditi Bagchi

2005
MUTATIONAL SIGNATURES AND IMMUNOPHENOTYPE IN RECURRENT MEDULLOBLASTOMA: AN INDICATION FOR NOVEL THERAPEUTIC APPROACH*  

Kelly Bailey

842

THE EWS-FLI1 ONCOPROTEIN LEVEL MODULATES CXCR4/CXCR7-NF-KB SIGNALING IN EWING SARCOMA.

Nitya Bakshi

666

PATIENTS WITH SICKLE CELL DISEASE AND THEIR CAREGIVERS WANT TO LEARN ABOUT BONE MARROW TRANSPLANT AS A TREATMENT OPTION

Michael Barbato

608

CNS TUMORS AND NEURODEVELOPMENTAL DISORDERS: A BRIEF SURVEY OF IN COMMON GENE ALTERATIONS

Gino Jose Bardi Lola

014
OSTEOSARCOMA IN A CHILD WITH NEUROFIBROMATOSIS TYPE 1: A CASE REPORT AND REVIEW OF THE LITERATURE.  

Erin Barr

829

THE EPIGENETIC MARKER 5-HYDROXYMETHYLCYTOSINE REVEALS DIFFERENTIAL PROFILES IN LOW-, INTERMEDIATE-, AND HIGH-RISK NEUROBLASTOMA AND IDENTIFIES COPY NUMBER
VARIANTS

Joy Bartholomew

827

OUTPATIENT INTERLEUKIN 2 MAY BE A SAFE AND FEASIBLE OPTION IN CHILDREN WITH HIGH RISK NEUROBLASTOMA

Allison Bartlett

066

HEREDITARY XEROCYTOSIS MISDIAGNOSED AS HEREDITARY SPHEROCYTOSIS

Jacquelyn Baskin

339
AURA ASSOCIATED WITH SICKLE CELL PAIN: A MOBILE PHONE APPLICATION TO STUDY THE RELATION BETWEEN THE DYSAUTONOMIA OF SICKLE CELL DISEASE AND SUBSEQUENT PAIN  

Allison Bechtel

516

A KNOWLEDGE SCREENING EDUCATION SYSTEM IN ADOLESCENTS WITH SICKLE CELL DISEASE

Allison Bechtel

822

ENTERAL TUBE NUTRITION NEEDS AND PERCEPTIONS IN HIGH-RISK HEAD AND NECK PEDIATRIC PATIENTS RECEIVING PROTON THERAPY

Kerri Becktell

046

RESOLUTION OF DIFFUSE LEPTOMENINGEAL ENHANCEMENT AFTER PRIMARY RESECTION OF ATYPICAL TERATOID/RHABDOID TUMOR

Tessa Bendyshe-Walton

649
DEVELOPMENT AND IMPLEMENTATION OF PHARMACOGENETIC RISK PREDICTION MODELS IN PEDIATRIC ONCOLOGY  

Heather Bernard

096

THE NOVEL USE OF DEFEROXAMINE IN A NEONATE WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II

Sucharita Bhaumik

047

PRIMARY EWINGS SARCOMA OF CERVICAL CORD MIMICKING CAUDA EQUINA SYNDROME

Sucharita Bhaumik

406

MEDICAL MANAGEMENT IN A CASE OF SPLENOSIS IN A RELAPSED IMMUNE THROMBOCYTOPENIC PURPURA PATIENT

Sucharita Bhaumik

512
MANAGEMENT OF EARLY SEPSIS IN NEUTROPENIC PEDIATRIC ONCOLOGY PATIENTS IN AN ARTICLE 28 INSTITUTION IN THE OUTPATIENT SETTING TO OPTIMIZE PATIENT OUTCOME.  

Nabanita Bhunia

818

TARGETING PHOSPHORYLATION OF EZRIN IN METASTATIC RHABDOMYOSARCOMA

Vandy Black

340

CLINICAL OUTCOMES OF CHILDREN WITH SICKLE CELL DISEASE HOSPITALIZED FOR FEVER

Vandy Black

611
EVALUATING THE PROFESSIONAL DEVELOPMENT NEEDS OF PEDIATRIC HEMATOLOGISTS-ONCOLOGISTS SERVING IN THE UNITED STATES MILITARY  

Lindsay Blazin

753

'I’M GOING TO CHURCH ANYWAY': THE IMPACT OF SPIRITUALITY ON GRIEVING FOR PARENTS WHO HAVE LOST CHILDREN TO CANCER

Ellen Bloom

329

PSYCHOSOCIAL RISK FACTORS OF SEVERITY OF SICKLE CELL DISEASE IN YOUNG CHILDREN

Julie Boiko

764

FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN AN ADOLESCENT PRESENTING WITH NEUROPSYCHIATRIC CHANGES IN THE ABSENCE OF CLASSIC SYSTEMIC SIGNS

Ashley Bonheur

053
A COMPLEX TRANSLOCATION INVOLVING CHROMOSOMES 2, 7, AND 12 IN A CASE OF PEDIATRIC WILMS TUMOR  

Geetanjali Bora

217

FACTORS AFFECTING BONE MINERAL DENSITY IN YOUNG CHILDREN AND ADOLESCENTS WITH TRANSFUSION DEPENDENT THALASSEMIA

Bruce Bostrom

749

CAN PROPHYLACTIC PAMIDRONATE INFUSIONS REDUCE THE INCIDENCE OF SYMPTOMATIC OSTEONECROSIS IN PATIENTS AT HIGH RISK?

Alexander Boucher

105

DOSE MODIFICATIONS AND PHARMACOKINETICS OF CISPLATIN MONOTHERAPY FOR THREE PATIENTS WITH LOW-RISK HEPATOBLASTOMA AND DIALYSIS-DEPENDENT END-STAGE RENAL DISEASE

Alisha Bouzaher

528
A PATIENT-CENTERED INTERVENTION TO IMPROVE THE TIME-TO-ANTIBIOTICS FOR PEDIATRIC FEBRILE NEUTROPENIA PATIENTS AT A LARGE ACADEMIC MEDICAL CENTER  

Leah Bruno

102

A CASE OF ATYPICAL HUS IN THE ABSENCE OF SCHISTOCYTES

Jochen Buechner

751

MANAGEMENT OF COAGULOPATHY ASSOCIATED WITH TISAGENLECLEUCEL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY

Kenneth Bujold

 

TREATMENT OF RELAPSED ACUTE MYELOID LEUKEMIA PRESENTING AS INTRACRANIAL MYELOID SARCOMA: A CASE SERIES

Kenneth Bujold

425
CONTINUOUS LOW-DOSE HEPARIN INFUSION FOR CATHETER RELATED THROMBOSIS PROPHYLAXIS IN CRITICALLY ILL CHILDREN  

James Bussel

421

FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)

James Bussel

427

A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)

Daniel Callaway

354

PHYSICAL THERAPY IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH SICKLE CELL DISEASE: ASSESSING POTENTIAL BENEFITS AND BARRIERS

Kevin Campbell

824
EWING SARCOMA VS. PNET: COMPARING EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOMES OVER 40 YEARS USING SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS DATA.  

Daniel Cannone

635

INITIAL SUCCESS OF AN INTERDISCIPLINARY COMMUNICATION COURSE FOR FELLOWS

Ivana Capin

024

A NOVEL APC MUTATION IN A TEENAGE PATIENT WITH A LARGE INTRA-ABDOMINAL DESMOID TUMOR

Maria Carter Febres

804

TARGETING BRAIN TUMOR STEM-LIKE CELLS WITH ATYPICAL ANTIPSYCHOTIC DRUGS

Christina Caruso

324
THE SIGNIFICANCE OF EARLY TRANSFUSION IN THE MANAGEMENT OF ACUTE CHEST SYNDROME IN PATIENTS WITH SICKLE CELL DISEASE  

Jamie Cashell

643

RETENTION OF VACCINE-MEDIATED HUMORAL IMMUNITY IN THE POST-THERAPY PEDIATRIC ONCOLOGY POPULATION

Angel Castro Dager

 330

STANDARDIZATION OF A NEW PARTIAL EXCHANGE TRANSFUSION PROTOCOL IN A PEDIATRIC POPULATION WITH SICKLE CELL DISEASE IN CARTAGENA, COLOMBIA

Priya Chan

 816

EXTRANEURAL METASTASES OF A WHO GRADE II EPENDYMOMA: A CASE REPORT AND REVIEW OF THE LITERATURE

Simone Chang

 091
MULTIPLE SITES OF EXTRAMEDULLARY RELAPSE ON BLINATUMOMAB: A PEDIATRIC CASE REPORT

 

Karen Chao

 770

MONOTHERAPY TREATMENT WITH CYTARABINE FOR ALK-POSITIVE HISTIOCYTOSIS IN AN INFANT

Chen-Chen Cheng

 624

BRING THE CLASS TO THE HOSPITAL: SUCCESS STORIES OF CHILDHOOD CANCER SURVIVORS RETURNING TO MIDDLE SCHOOL IN TAIWAN AND WHAT WE CAN LEARN FROM THEM

May Chien

 054

CLINICAL OUTCOME OF HB KHARTOUM/β THALASSEMIA COMPOUND HETEROZYGOSITY: A GLIMPSE INTO HOMOZYGOUS HB KHARTOUM

May Chien

 430
ANTICOAGULATION FOR TREATMENT OF PAIN IN VENOUS MALFORMATIONS

 

Soohee Cho

 061

CHOLELITHIASIS IN PATIENTS WITH CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES

Florence Choo

 523

ADHERENCE TO ANTIEMETIC GUIDELINES IN PEDIATRIC PATIENTS WITH CANCER: HOW DO WE TRANSLATE EVIDENCE INTO PRACTICE?

Trixy Chu

 737

SURVIVAL OF FILIPINO CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSED IN A TERTIARY REFERRAL CENTER FOR CHILDHOOD CANCER: A RETROSPECTIVE COHORT STUDY

David Claassen

 311
CHARACTERIZATION, TREATMENT, AND TOXICITIES IN A PEDIATRIC DIAMOND BLACKFAN ANEMIA COHORT

 

Allison Close

 110

THE PROOF IS IN THE PUDDING: A CASE OF COPPER DEFICIENCY CAUSING CYTOPENIAS IN A FOOD RESTRICTED CHILD

Allison Close

 520

IMPROVING THE EVALUATION AND MANAGEMENT OF ABNORMAL UTERINE BLEEDING IN ADOLESCENT FEMALES PRESENTING TO EMERGENCY CARE

Clay Cohen

 440

FIRST CASE OF CYTOPENIAS IN THE SETTING OF CEREBRAL CAVERNOUS MALFORMATION 3

Christina Coleman Abadi

 020
PROLONGED SURVIVAL AND EVENTUAL DEATH BY DISSEMINATED PULMONARY METASTASIS IN A PEDIATRIC PATIENT WITH DIFFUSE PONTINE H3.1K27M GLIOMA: A CASE REPORT

 

James Cooper

 437

VON WILLEBRAND DISEASE, DDAVP, AND FLUID MANAGEMENT IN PEDIATRIC SURGICAL PATIENTS

Stacy Cooper

 506

COMMUNICATION OF PEDIATRIC CANCER DIAGNOSES: THE EXPERIENCES OF CAREGIVERS, PATIENTS AND GENERAL PEDIATRIC PROVIDERS

Elizabeth Cowell

 826

DEFINITION OF RISK PROFILE AND TOXICITIES OF HIGH-DOSE METHOTREXATE USE IN PEDIATRIC OSTEOSARCOMA

Shelley Crary

 418
EFFECT OF SIROLIMUS ON COAGULOPATHY OF SLOW-FLOW VASCULAR MALFORMATIONS

 

Ashley Cronkright

 215

THE FAMILIES WITH ADOPTED CHILDREN WITH THALASSEMIA STUDY (FACT STUDY)

Courtney Culbertson

 641

NUTRTIONAL STATUS AND NUTRIONAL SUPPORT THERAPY AFTER ONCOLOGIC DIAGNOSIS: A RETROSPECTIVE, DESCRIPTIVE STUDY

Ahmed Daak

 2012

ClINICAL EFFECT OF SC411 (AlTEMIA TM) ON CHILDREN WITH SICKLE CELL DISEASE IN THE SCOT TRIAL: A PHASE 2 RANDOMIZED, DOUBL-BLIND, PLACEBO-CONTROLED, RALLEL-GROUP, DOSE-FINDING MULTI-CENTER STUDY*

Ahmed Daak

 353
EFFECTS OF SC411 (ALTEMIATM) ON BLOOD CELL MEMBRANE OMEGA-3 INDEX AND SELECT SICKLE CELL DISEASE BIOMARKERS IN THE SCOT TRIAL: A Phase 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-COMTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY

 

Scott Daigle

 2007

PHASE 1 STUDY OF THE EZH2 INHIBITOR, TAZEMETOSTAT, IN CHILDREN WITH RELAPSED OR REFRACTORY INI1-NEGATIVE TUMORS INCLUDING RHABDOID TUMORS, EPITHELIOID
SARCOMA, CHORDOMA; AND SYNOVIAL SARCOMA*

Monica Davini

 525

ROUTINE IMAGING FOR DETECTION OF RELAPSE AND ASSESSING TREATMENT RESPONSE IN ALPHA FETO PROTEIN (AFP) POSITIVE HEPATOBLASTOMA- IS IT REALLY NECESSARY?

Matthew Davis

 2008

CHANGES IN ANTIEMETIC PRESCRIBING PRACTICES FOR CHILDREN RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY*

Kyle Davis

 415
HEMATURIA PREVALENCE IN PEDIATRIC PATIENTS WITH HEMOPHILIA: A NATIONAL DATABASE REVIEW

 

Michelina de la Maza

 208

ABATACEPT FOR MANAGEMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA

Jennifer Dean

 636

PHYSICAL ACTIVITY INITIATIVE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS: A PILOT STUDY

Christopher Denton

 350

METHODOLOGICAL DIFFERENCES IN MEASUREMENT ALTERS AGGREGATION RESULTS IN PATIENTS WITH SICKLE CELL DISEASE VERSUS HEALTHY SUBJECTS

Brittany DePriest

 914
ASSESSMENT OF IRON OVERLOAD IN THE PEDIATRIC ALLOGENEIC HSCT RECIPIENT

 

Yaser Diab

 409

EXTREMITY DEEP VENOUS THROMBOSIS IN ASSOCIATION WITH VENOUS ANATOMIC ABNORMALITIES: INCIDENCE, CHARACTERISTICS AND OUTCOMES OF MULTIDISCIPLINARY CARE AT A SINGLE PEDIATRIC CENTER

Yaser Diab

 423

ACUTE INFECTIONS AND VENOUS THROMBOEMBOLISM IN CHILDREN: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

Rosa Diaz

 439

PREVALENCE AND BLEEDING PHENOTYPE OF COMBINED DEFICIENCIES IN FACTOR VIII AND VON WILLEBRAND FACTOR

Dragon Do

 722
EFFECTS OF DISRUPTION OF PIRNA PATHWAY IN AML CELL LINES TREATED WITH DNA METHYLTRANSFERASE INHIBITORS

 

Erin Doherty

 708

INDUCIBLE COSTIMULATION TO ENHANCE THE ANTI-AML ACTIVITY OF CD123-ENG T-CELLS

Elizabeth Donovan

 626

A PATIENT-CENTERED APPROACH TO DEVELOPING A MOBILE-BASED PSYCHOSOCIAL INTERVENTION FOR ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA

Lauren Draper

 519

CAREGIVER DECISION-MAKING REGARDING ENROLLMENT IN CHILDREN'S ONCOLOGY GROUP THERAPEUTIC TRIALS

Lucy Duan

 438
LIFE-THREATENING EFFUSIONS IN KAPOSIFORM HEMANGIOENDOTHELIOMA RESPONDING TO ORAL RAPAMYCIN

 

Caitlyn Duffy

 717

STEROID INDUCED BRADYCARDIA IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Olive Eckstein

 754

CLINICAL OUTCOMES WITH MAPK INHIBITION IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS

Karen Effinger

 604

OUTCOMES WITHIN FIVE YEARS FROM THERAPY COMPLETION IN PEDIATRIC HODGKIN LYMPHOMA PATIENTS FOLLOWING CONTEMPORARY THERAPY

Karen Effinger

 614
WORKING TO STANDARDIZE CARDIOLOGY CARE IN SURVIVORS OF CHILDHOOD CANCER: A PEDIATRIC CARDIO-ONCOLOGY SCORE

 

Ahmed Elgammal

 742

DOES CONSOLIDATION RADIOTHERAPY IMPROVES THE OUTCOME OF CHILDREN WITH STAGE IV HODGKIN LYMPHOMA IN COMBINATION TO CHEMOTHERAPY?

Ahmed Elhussein

 744

ROLE OF FDG-PET/CT IN THE MANAGEMENT OF PEDIATRIC BURKITT LYMPHOMA

Hannah Elkus

 814

IMPACT OF INFECTIONS ON SURVIVAL IN PEDIATRIC PATIENTS WITH BONE TUMORS

Amr Elnashar

 761
PROTECTIVE EFFECT OF DICLOFENAC AND ENOXAPARIN IN L-ASPARAGINASE INDUCED ACUTE PANCREATITIS IN RATS

 

Elissa Engel

 056

SUCCESSFUL USE OF ELTROMBOPAG IN A PEDIATRIC PATIENT WITH HIV-RELATED THROMBOCYTOPENIA

Huseyin Erdemir

 748

INCREASED TUMOR GROWTH AND ANGIOGENESIS IN ABSENCE OF KININOGEN IN T-CELL LYMPHOMA MURINE MODEL

Adam Esbenshade

 602

PREVALENCE OF INTERNALIZING PROBLEMS IN PEDIATRIC CANCER PATIENTS AT ENTRY INTO A SURVIVORSHIP CLINIC

Adam Esbenshade

 664
INDICATIONS FOR EXPANSION OF EMPIRIC ANTIBIOTIC COVERAGE IN FEBRILE NEUTROPENIA IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS

 

Orlando Esparza

 071

A UNIQUE PHENOTYPE OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A PATIENT WITH GATA2 DEFICIENCY

Justin Farge

 735

GRANULOCYTIC SARCOMAS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES

Sana Farooki

 031

SAMD9 MUTATION ASSOCIATED BONE MARROW FAILURE TREATED WITH BONE MARROW TRANSPLANT: A UNIQUE TREATMENT APPROACH TO A RARE CASE

Sameer Farouk Sait

 026
EXTRANEURAL METASTASES IN PEDIATRIC GLIOBLASTOMA MULTIFORME - A CASE REPORT AND LITERATURE REVIEW

 

Titilope Fasipe

 310

IDENTIFICATION OF SICKLE CELL SUPER-UTILIZATION, A SINGLE INSTITUTION EXPERIENCE

Mohamed Fawzy

 833

WATCH AND SEE STRATEGY IN SELECTED NEUROBLASTOMA CASE SCENARIOS; SUCCESS AND LIMITATIONS

Kathleen Felton

 021

DIAGNOSIS AND MANAGEMENT OF VON WILLEBRAND DISEASE TYPE 2B IN A PATIENT WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Angela Feraco

 651
THE DAY 100 TALK: FEASIBILITY AND ACCEPTABILITY OF A STRUCTURED INTERDISCIPLINARY COMMUNICATION INTERVENTION TARGETED TO THE EARLY TREATMENT PERIOD FOR
CHILDHOOD CANCERS

 

Karen Fernandez

 087

RITUXIMAB FOR ADVANCED BURKITT LYMPHOMA IN A PATIENT WITH DEFECTIVE CELL MEDIATED IMMUNITY DUE TO CARTILAGE-HAIR HYPOPLASIA (CHH)

Karen Fernandez

 422

UNDERSTANDING THE IMMUNE STATUS OF PATIENTS WITH NON-COMPLICATED VASCULAR OR LYMPHATIC ANOMALIES TREATED WITH SIROLIMUS

Karen Fernandez

 736

RARE PRESENTATIONS OF HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS: A MULTICENTER EXPERIENCE IN LATIN AMERICA AND THE UNITED STATES

Karen Fernandez

 746
HODGKIN LYMPHOMA AND TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN GUATEMALA AND ARGENTINA

 

Patrick Fogarty

 435

ANALYSIS OF REAL-WORLD CLAIMS DATA ASSOCIATED WITH A STANDARD AND AN EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCT IN U.S. PEDIATRIC PATIENTS WITH
HEMOPHILIA B

Kayla Foster

 060

CONGENITAL SIDEROBLASTIC ANEMIA, IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY SYNDROME MASQUERADING AS ALPHA THALASSEMIA VARIANT

Ashley Foster Lanzel

 412

ETHICAL DECISION MAKING FRAMEWORK IN PREVIOUSLY UNTREATED SEVERE HEMOPHILIA A PATIENTS

Ashley Foster Lanzel

 665
DECISION-MAKING IN THE FACE OF INCURABLE HIGH GRADE GLIOMAS: A QUALITATIVE ETHICAL ANALYSIS

 

Ellen Fraint

 916

UNUSUAL NEUROLOGIC SEQUELAE AFTER POST-TRANSPLANT ACUTE LIMBIC ENCEPHALITIS DUE TO HHV-6 INFECTION

Natasha Frederick

 645

IDENTIFYING OPPORTUNITIES FOR IMPROVED COMMUNICATION BETWEEN ADOLESCENT AND YOUNG ADULT ONCOLOGY PATIENTS AND THEIR ONCOLOGY CLINICIANS

Natasha Frederick

 667

LET'S TALK ABOUT SEX: ADOLESCENT AND YOUNG ADULT CANCER PATIENT SEXUAL AND REPRODUCTIVE HEALTH COMMUNICATION NEEDS

Carol Fries Simpson

 074
WHEN THE HISTORY TELLS THE STORY: A CASE OF VITAMIN B12 DEFICIENCY DISCOVERED IN AN EXCLUSIVELY BREASTFED INFANT WITH PALLOR AND FAILURE TO THRIVE

 

Carol Fries Simpson

 745

ULTRA-DEEP SEQUENCING DEMONSTRATES VARYING CLONAL COMPOSITION BETWEEN DISEASE SITES IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B ALL)

Carol Fries Simpson

 918

HIGH DOSE CHEMOTHERAPY WITH CARBOPLATIN AND THIOTEPA WITH AUTOLOGOUS STEM CELL RESCUE IS A FEASIBLE AND WELL-TOLERATED THERAPY FOR MALIGNANT CNS TUMORS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE

Jordan Fritch

 830

COMBINATION THERAPY OF POLYMERIC CHLOROQUINE AND DOXORUBICIN TO TREAT PULMONARY METASTATIC OSTEOSARCOMA

Stephanie Fritch Lilla

 209
SHORT-TERM HIGH-DOSE INTRAVENOUS DEFEROXAMINE AS COMBINATION THERAPY FOR REDUCTION OF IRON IN PATIENTS WITH PERSISTENT IRON OVERLOAD

 

Kari Galipp

 090

DIAGNOSING VITAMIN B12 DEFICIENCY ANEMIA IN A CHILD WITH A COMPLEX HEMATOLOGICAL PRESENTATION

Kari Galipp

 092

CASE REPORT: CYCLIC NEUTROPENIA AND ASSOCIATED AMYLOIDOSIS

Rachel Gallant

 621

A PROSPECTIVE PROTOCOL TO ASSESS RATES OF BACTERIAL RESISTANCE TO CEFTRIAXONE IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS WITH FEBRILE NEUTROPENIA

Sophie Gatineau-Sailliant

 711
IMPACT OF GENETIC POLYMORPHISMS DETERMINING LEUKOCYTE/NEUTROPHIL COUNT ON INDUCTION TOXICITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A COMPLEMENTARY STUDY

 

Sophie Gatineau-Sailliant

 760

LANGERHANS CELL HISTIOCYTOSIS WITH VERTEBRAL INVOLVEMENT DIAGNOSED IN A SINGLE CANADIAN PEDIATRIC ACADEMIC INSTITUTION

Jessica Geaney

 619

REDUCTION IN RISK OF BACTEREMIA BASED ON RESPIRATORY PATHOGEN PANEL RESULTS

Jessica Geaney

 755

IMPORTANCE OF UTILIZING MULTIPLE OBJECTIVE MEASURES OF ADHERENCE IN PEDIATRIC CANCER: COMPARISON BETWEEN PHARMACOLOGICAL ASSAYS AND BEHAVIORAL ADHERENCE

Erin Gelgoot

 657
TRANSITION OF CARE FOR YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER

 

Majd Ghanim

 111

EXCEPTIONAL CLINICAL RESPONSE TO MOLECULAR GUIDED THERAPY IN A PATIENT WITH PROGRESSIVE LYMPHOEPITHELIOMA-LIKE THYMIC CARCINOMA

Majd Ghanim

 058

SUCCESSFUL SUPPRESSION OF FACTOR VIII INHIBITOR TITERS WITH IMMUNE TOLERANCE INDUCTION IN AN INFANT WITH SEVERE HEMOPHILIA A DUE TO EXON DUPLICATION

Maurizio Ghisoli

 811

TARGETING EWS-FLI1 DRIVING GENE: PRELIMINARY DATA OF PHASE 1 PBI-ShRNA EWS/FLI1 LIPOPLEX

Katrina Gleditsch

 081
A NOVEL DE NOVO HETEROZYGOUS MUTATION IN THE PCDH17 GENE WITH MICROCEPHALY, DEVELOPMENTAL DELAY AND HISTORY OF ACUTE LYMPHOBLASTIC LEUKEMIA

 

Prabudh Goel

 819

LAPAROSCOPIC MANAGEMENT OF INTRA - ABDOMINAL TUMORS - FEASIBLE OR NOT?

Alyssa Goodman

 658

MEASURING LEVELS OF STRESS IN PARENTS OF CHILDREN WHO HAVE RECENTLY COMPLETED CANCER TREATMENT

Hamza Gorsi

 004

A CASE REPORT OF SPONTANEOUS EXPECTORATION OF PULMONARY METASTASES IN A CHILD WITH OSTEOGENIC SARCOMA.

Hamza Gorsi

 650
THE ASSOCIATION OF BLOCK GROUP POVERTY STATUS AND EXECUTIVE FUNCTIONING AMONG CHILDHOOD CANCER SURVIVORS

 

Nathan Gossai

 732

BVGP: A NOVEL PROTOCOL FOR HODGKIN'S LYMPHOMA WITH EXCELLENT RESPONSE, MINIMAL ACUTE TOXICITIES AND REDUCED RISK OF LATE EFFECTS

Derrick Goubeaux

 048

AN UNUSUAL ANAPHYLACTIC RESPONSE TO TREATMENT IN A PATIENT WITH SEVERE TYPE 1 VON WILLEBRAND DISEASE

Madhu Gowda

 644

CANCER SURVIVORS WHO EXERCISE REGULARLY SEE IMPROVEMENTS IN PHYSICAL FITNESS EVEN WITHOUT WEIGHT LOSS.

Chandrika Gowda

 704
UNDERSTANDING PEDIATRIC LEUKEMIA HEALTH DISPARITY: REGULATION OF CRLF2 BY IKAROS AND CASEIN KINASE II

 

Chandrika Gowda

 716

ROLE OF RHO-GTPASE CDC42 IN LEUKEMIA AND ITS REGULATION BY IKAROS AND CASEIN KINASE II

Matthew Grant

 063

USE OF EXTRACORPOREAL MEMBRANE OXYGENATION IN A PATIENT WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA DESPITE COAGULOPATHY AND HEMORRHAGE

Katie Greenwood

 023

DIAGNOSIS AND MANAGEMENT OF A NOVEL PHENOTYPE OF IMMUNODEFICIENCY, CENTROMERIC INSTABILITY, AND FACIAL ANOMALY SYNDROME (ICF) TYPE 4 WITH NEUTROPENIA AND NEUROBLASTOMA

Caroline Gross

 769
DIVIDE AND CONQUER: EVALUATION OF A REDESIGN FOR INPATIENT PEDIATRIC ONCOLOGY SERVICE

 

Joanna Grossman Newton

 526

CHANGING BLOOD CULTURE STRATEGY: A QUALITY IMPROVEMENT PROJECT TO ELIMINATE THE PRACTICE OF AUTOMATIC DAILY BLOOD CULTURES IN HOSPITALIZED PEDIATRIC PATIENTS WITH FEVER AND NEUTROPENIA

Liron Grossmann

 332

VON WILLEBRAND FACTOR ANTIGEN AND MULTIMERS AS BIOMARKERS IN YOUNG PATIENTS WITH SICKLE CELL DISEASE

Liron Grossmann

 911

HIGH INCIDENCE OF THROMBOTIC MICROANGIOPATHY IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS WITH MULTIPLE BLOODSTREAM INFECTIONS

Stephanie Gruner

 079
PONATINIB USE IN PEDIATRIC/ADOLESCENT AND YOUNG ADULT PATIENTS WITH RELAPSED PH+ ALL: A CASE SERIES AND REVIEW OF THE LITERATURE

 

Arun Gurunathan

 309

DELAYED OR INCORRECT DIAGNOSIS OF β-THALASSEMIA: α-GLOBIN GENE TRIPLICATION AS A COVERT GENETIC MODIFIER

Arun Gurunathan

 817

CLINICAL UTILITY OF PET/CT IN PATIENTS WITH PIGMENTED VILLONODULAR SYNOVITIS TREATED WITH IMATINIB

Hadeel Halalsheh

 813

THE ROLE OF ROUTINE IMAGING IN CHILDHOOD MELANOMA (MM)

Sarah Hall

 413
EVALUATION OF THE HYPERMOBILE PATIENT IN BLEEDING DISORDERS CLINIC: REPORTS OF COMORBID EHLERS-DANLOS SYNDROME AND VON WILLEBRAND DISEASE

 

Katharine Halligan

 050

USE OF ECULIZUMAB IN A PATIENT WITH REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA WITH HETEROZYGOUS NFKB1 MUTATION

Katharine Halligan

 637

COMMUNICATION SKILLS TRAINING FOR PEDIATRIC RESIDENTS: LEARNING TO GIVE BAD NEWS

Tyler Hamby

 729

PREVALENCE AND RISK FACTORS FOR MALNUTRITION DURING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA INDUCTION THERAPY

Jennifer Han

 032
THE COMBINATION OF SORAFENIB AND CAPECITABINE IN RECURRENT FIBROLAMELLAR HEPATOCELLULAR CARCINOMA: A NOVEL ORAL CHEMOTHERAPY APPROACH

 

Steven Hardy

 341

A RANDOMIZED CONTROLLED TRIAL OF HOME-BASED COMPUTERIZED WORKING MEMORY TRAINING FOR CHILDREN WITH SICKLE CELL DISEASE

Steven Hardy

 343

DISCRIMINATING CEREBRAL INFARCTS IN PEDIATRIC SICKLE CELL DISEASE USING BRIEF COMPUTERIZED NEUROCOGNITIVE ASSESSMENTS

Kip Hartman

 008

DESMOPLASTIC SMALL ROUND CELL TUMOR OF THE CENTRAL NERVOUS SYSTEM

Susan Harvey

 211
ESTABLISHING REFERENCE RANGES FOR COMPLETE BLOOD COUNTS IN CHILDREN WITH DOWN SYNDROME

 

Saman Hashmi

 718

THE UNFOLDED PROTEIN RESPONSE AS A PREDICTOR OF CHEMOSENSITIVITY IN PEDIATRIC ACUTE MYELOID LEUKEMIA

Cassandra Hastings

 638

HETEROGENEITY IN SCHOOL RE-ENTRY PROGRAMS FOR CHILDREN RETURNING TO SCHOOL FOLLOWING TREATMENT FOR CANCER

Jessica Heath

 2022

TRANSCRIPTIONAL CO-REGULATION BY IKAROS AND RUNX1 IN MYELOID LEUKEMIA*

Jessica Heath

 075
PROTRACTED ANAPHYLAXIS AFTER PEG-ASPARAGINASE: ACUTE MANAGEMENT AND SUBSEQUENT ASPARAGINASE TOLERANCE

 

Cristiana Hentea

 034

GENETIC CHARACTERIZATION OF BILATERAL NEUROBLASTOMA USING WHOLE EXOME SEQUENCING

Cristiana Hentea

 613

SOCIOECONOMIC IMPACT ON PARENTAL TREATMENT RATES OF PAIN AND NAUSEA

Sebastian Hesse

 207

INTERROGATING THE HUMAN NEUTROPHIL GRANULOCYTE IN MONOGENIC DISEASE BY NEXT GENERATION PROTEOMICS

Kayeleigh Higgerson

 832
CHARACTERIZATION OF LOCALIZED OSTEOSARCOMA OF THE EXTREMITY IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS FROM SOUTH TEXAS: INCREASING INSIGHT INTO HISPANIC POPULATIONS.

 

Kirsty Hillier

 835

FACTORS IMPACTING TIME TO ENGRAFTMENT IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT

Jessica Hochberg

 752

REDUCED BURDEN OF ONCOLOGIC THERAPY IN ADVANCED B-CELL LYMPHOMA IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH CD20+ MATURE B-CELL LYMPHOMA

Inga Hofmann

 205

CONGENITAL THROMBOCYTOPENIA AND MYELOFIBROSIS DUE TO GERMLINE MUTATIONS IN G6B-B

Andrew Hong

 803
IDENTIFYING MOLECULARLY DEFINED TARGETS IN HIGH RISK RENAL TUMORS FROM PATIENT DERIVED MODELS

 

Alex Hoover

 108

SWEATING BLOOD: A CASE SERIES OF TWO SIBLINGS WITH HEMATOHIDROSIS

Amy Houghtelin

 2006

EX VIVO EXPANDED MULTI-ANTIGEN SPECIFIC LYMPHOCYTES FOR THE TREATMENT OF SOLID TUMORS*

Frederick Huang

 501

PARENTAL EDUCATION OF THE CENTRAL LINE CARE BUNDLE IS ASSOCIATED WITH A LOWER AMBULATORY CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTION RATE

Ionela Iacobas

 428
GUIDANCE DOCUMENT FOR HEPATIC HEMANGIOMA (INFANTILE AND CONGENITAL) EVALUATION AND MONITORING

 

Azada Ibrahimova

 618

COMPARISON OF INPATIENT MORTALITY AND SUPPORTIVE CARE UTILIZATION IN INFANTS AND NON-INFANTS WITH ACUTE LEUKEMIA

Fiorella Iglesias

 040

PRIMARY LEPTOMENINGEAL MEDULLOBLASTOMA: A RARE PRESENTATION OF MEDULLOBLASTOMA IN A CHILD

Noreen Islam

 402

FACTOR XIIIA1 GENE VARIANTS IN THREE SIBLINGS WITH VARYING BLEEDING PHENOTYPES

Vishesh Jain

 821
TREATMENT OUTCOMES OF MALIGNANT GERM CELL TUMOR: A SINGLE CENTRE EXPERIENCE OF 22 YEARS

 

Michael Jeng

 758

LANGERHANS CELL HISTIOCYTOSIS: GASTROINTESTINAL INVOLVEMENT IN CHILDREN

Nina Kadan-Lottick

 653

ASSOCIATION OF HEARING LOSS WITH COGNITIVE AND EMOTIONAL FUNCTIONING IN NON-CNS TUMOR CHILDHOOD CANCER SURVIVORS TREATED WITH PLATINUM-BASED CHEMOTHERAPY

Nina Kadan-Lottick

 646

TELEPHONE COMMUNICATION BETWEEN NURSES AND PRIMARY CARE PHYSICIANS (PCPS) USING THE SITUATION, BACKGROUND, ASSESSMENT, AND RECOMMENDATION (SBAR) TOOL TO COORDINATE SURVIVORSHIP CARE: A FEASIBILITY STUDY

Meena Kadapakkam

 839
B7-H3 CAR T CELLS MEDIATE IN VITRO AND IN VIVO ACTIVITY AGAINST NEUROBLASTOMA XENOGRAFTS

 

Alissa Kahn

 052

AN UNLIKELY PRESENTATION OF A RARE COMBINATION: A CASE SERIES OF ALPHA GLOBIN GENE TRIPLICATION ASSOCIATED WITH BETA THALASSEMIA TRAIT IN HISPANIC PATIENTS

Julie Kanter Washko

 203

CRIZANLIZUMAB 5.0 MG/KG INCREASED THE TIME TO FIRST ON-TREATMENT SICKLE CELL PAIN CRISIS (SCPC) AND THE LIKELIHOOD OF NOT EXPERIENCING SCPC WHILE ON TREATMENT: SUBGROUP ANALYSES OF THE PHASE 2 SUSTAIN STUDY

Julie Kanter Washko

 503

RESULTS OF A NATIONAL PROVIDER SURVEY IN SICKLE CELL DISEASE MANAGEMENT

Julie Kanter Washko

 601
QUALITY OF CARE IN US CHILDREN WITH SICKLE CELL DISEASE

 

Aroop Kar

 738

BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION: A DISTINCT PATHOLOGIC AND CLINICAL ENTITY

Nicole Kendel

 403

CHARACTERIZING ADOLESCENTS WITH HEAVY MENSTRUAL BLEEDING AND GENERALIZED JOINT HYPERMOBILITY

Paul Kent

 009

SIADH DUE TO HIGH-DOSE METHOTREXATE

Paul Kent

 762
LANGERHANS CELL HISTIOCYTOSIS THERAPY FOR THE TREATMENT OF LIFE-THREATENING ROSAI DORFMAN DISEASE

 

Jennifer Kesselheim

 625

HUMANISM AND PROFESSIONALISM TRAINING IN PEDIATRIC HEMATOLOGY-ONCOLOGY FELLOWSHIP: RESULTS OF A MULTI-CENTER RANDOMIZED TRIAL

Dilruba Khanam

 080

COMPLEXITY IN THE DIAGNOSIS OF MYOSIN HEAVY CHAIN 9-RELATED PLATELET DISORDER IN A PEDIATRIC PATIENT WITH ASYMPTOMATIC THROMBOCYTOPENIA

Kirshma Khemani

 333

UNANTICIPATED CONSEQUENCES IDENTIFIED AFTER IMPLEMENTATION OF A PEDIATRIC EMERGENCY DEPARTMENT (PED)-BASED INTRANASAL FENTANYL (INF) PROTOCOL FOR THE TREATMENT OF VASO-OCCLUSIVE PAIN EPISODES (VOE) IN CHILDREN WITH SICKLE CELL DISEASE (SCD)

Ruby Khoury

 915
ISLAM, THE QUR'AN, AND MEDICAL DECISION-MAKING – THE EXPERIENCE OF MIDDLE EASTERN MUSLIM FAMILIES WITH CHILDREN UNDERGOING STEM CELL TRANSPLANTATION IN THE UNITED STATES

 

Hiroto Kiguchi

 629

BUILDING RESILIENCE DURING PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWSHIP: IMPLEMENTING SYSTEMATIC DEBRIEFING SESSIONS AND RESILIENCY CURRICULUM TO SUPPORT TRAINEES

Hyery Kim

 807

THE EFFICACY OF INTENSIFIED ADJUVANT CHEMOTHERAPY IN OSTEOSARCOMA PATIENTS WITH METASTATIC DISEASE OR POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY

Trisha Kissoon

 908

PARVOVIRUS B19 INFECTION MANIFESTING AS CYTOPENIA IN CONSTELLATION WITH BONE PAIN POST HEMATOPOIETIC STEM CELL TRANSPLANTATION

Jacquelyn Klicka-Skeels

 344
CORRELATION BETWEEN HYDROXYUREA USE AND LEFT VENTRICULAR REMODELING AND FUNCTION IN CHILDREN WITH SICKLE CELL DISEASE

 

Tristan Knight

 902

DIFFERING INCIDENCE AND PATTENRS OF CLOSTRIDIUM DIFFICILE INFECTION AMONG PEDIATRIC HEMATOLOGY, ONCOLOGY, AND HEMATOPOIETIC STEM CELL TRANSPLANTATION INPATIENT POPULATIONS

Melissa Knudson

 336

EFFECT OF HYDROXYUREA AND CHRONIC PRBC TRANSFUSIONS ON PULMONARY FUNCTION DECLINE IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE

Prachi Kothari

 809

NONINVASIVE MOLECULAR PROFILING BY CIRCULATING CELL-FREE DNA IN PEDIATRIC SOLID TUMORS

Sara Kreimer

 802
HDAC INHIBITION IN THALAMIC AND SPINAL CORD H3K27M+ DIFFUSE MIDLINE GLIOMA

 

Lakshmanan Krishnamurti

 338

COMPARATIVE EFFECTIVENESS OF A PATIENT DECISION AID FOR THERAPEUTIC OPTIONS FOR SICKLE CELL DISEASE

Sairam Kumar

 328

BIOMARKERS TO PREDICT SEVERITY OF SICKLE CELL VASO-OCCLUSIVE CRISIS IN THE PEDIATRIC AGE GROUP

Theodore Laetsch

 703

TISAGENLECLEUCEL (CTL019) THERAPY APPEARS SAFE AND EFFECTIVE IN PEDIATRIC PATIENTS WITH DOWN SYNDROME WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA

Jessica Lake

 016
A LOW-GRADE GLIOMA HISTOLOGICALLY DIAGNOSED AS AN EPENDYMOMA: HOW MOLECULAR DATA IS SHAPING THE WAY WE DIAGNOSIS AND TREAT BRAIN TUMORS

 

Samuele Renzi

 036

EMBRYONAL RHABDOMYOSARCOMA SHOWING A NEW TRANSLOCATION (2:15): A CASE REPORT AND REVIEW OF THE LITERATURE

Benjamin Larsen

 351

MANAGEMENT OF ACUTE SPLENIC SEQUESTRATION CRISIS: A CLINICAL PRACTICE SURVEY

Courtney Lawrence

 401

CONTINUOUS ANTITHROMBIN INFUSION PROTOCOL TO OVERCOME HEPARIN RESISTANCE IN PEDIATRIC EXTRACORPOREAL MEMBRANE OXYGENATION: A SINGLE-CENTER EXPERIENCE

Zach Leblanc

 901
PANETH CELL COUNTS INDEPENDENTLY PREDICT ACUTE GASTROINTESTINAL GVHD STAGE AND RESPONSE TO THERAPY

 

YoungNa Lee-Kim

 505

STRATEGIES FOR IMPLEMENTING AN EFFECTIVE MORBIDITY, MORTALITY, AND IMPROVEMENT (MMI) CONFERENCE

Kathryn Lemberg

 515

APPLICATION OF A HOSPITAL-WIDE BLOOD CULTURE CLINICAL DECISION ALGORITHM TO AN INPATIENT PEDIATRIC ONCOLOGY POPULATION: A FELLOW-LED QUALITY IMPROVEMENT PROJECT

Alicia Lenzen

 808

IMMUNOTHERAPEUTIC NANOTECHNOLOGY TARGETING IDO1 FOR PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA

Yixian Li

 104
A PATIENT WITH MACROCYTIC ANEMIA AND PLATELET DYSFUNCTION ASSOCIATED WITH A NOVEL VARIANT OF GATA1 MUTATION

 

Nicole Liberio

 913

INVESTIGATING THE ROLE OF CELLULAR CONTENT AND GVHD IN DONOR LYMPHOCYTE INFUSIONS TO TREAT PEDIATRIC HEMATOLOGIC MALIGNANCIES: A SINGLE-CENTER LONG-TERM STUDY

Jaime Libes

 025

PEDIATRIC USE OF A DENVER SHUNT: ANSWER TO A FAMILY’S GOALS OF CARE

Jaime Libes

 057

ACHROMOBACTER XYLOSOXIDANS SEPTIC SHOCK: RARE CASE IN A PEDIATRIC PATIENT WITH RELAPSED NEUROBLASTOMA

Jaime Libes

 097
PERITONEAL DISSEMINATION OF BRAF FUSION POSITIVE HIGH GRADE NEUROEPITHELIAL TUMORS IN A CHILD WITH A VENTRICULO-PERITONEAL SHUNT PLACED FOR A BRAF-FUSION POSITIVE LOW GRADE GLIOMA

 

Jaime Libes

 107

MULTIVISCERAL ORGAN TRANSPLANTATION IN A 16-YEAR-OLD MALE WTH FIBROLAMELLAR HEPATOCELLULAR CARCINOMA

Amanda Lipsitt

 007

A CLINICAL DESCRIPTION AND MEDICAL MANAGEMENT OF “STIGMATA”

Shi Lixiao

 747

FUNCTION AND MECHANISM OF PI3K/AKT SIGNALING PATHWAY IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Michell Lozano Chinga

 028
OCCURRENCE OF CUTANEOUS MYELOID SARCOMA IN A PATIENT WITH A HISTORY OF OVARIAN YOLK SAC TUMOR

 

Hannah Lust

 095

CYTOKINE RELEASE SYNDROME AS A COMPLICATION OF SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA THERAPY

Hannah Lust

 640

RETROSPECTIVE STUDY OF NEUROLOGIC, BEHAVIORAL, AND OPHTHALMOLOGIC SIDE EFFECTS OF DINUTUXIMAB THERAPY AT A SINGLE INSTITUTION

Megan Lyle

 326

QUALITY IMPROVEMENT INITIATIVE TO INCREASE INCENTIVE SPIROMETRY USE IN HOSPITALIZED CHILDREN WITH SICKLE CELL DISEASE

Rebecca MacDonell-Yilmaz

 444
MULTIFOCAL LYMPHANGIOENDOTHELIOMATOSIS WITH THROMBOCYTOPENIA: DIAGNOSIS AND TREATMENT OF AN INFANT WITH UNCOMMON FINDINGS OF A RARE DISORDER

 

Manasi Vivek Madiwale

 652

YIELD OF SCREENING ECHOCARDIOGRAMS DURING TREATMENT AND IN THE EARLY POST-THERAPY PERIOD IN CHILDHOOD CANCER

Priya Mahajan

 002

MAMMARY ANALOGUE SECRETORY CARCINOMA IN CHILDREN: A REPORT FROM THE TEXAS CHILDREN'S RARE TUMOR REGISTRY

Priya Mahajan

 432

PEDIATRIC HEAD AND NECK LYMPHATIC MALFORMATIONS: PRENATAL PLANNING AND MANAGEMENT STRATEGIES IN THE MULTIMODAL ERA

Mona Mohamed Hamdy Mahmoud

 214
ASSESSMENT OF QUALITY OF LIFE AMONG B -THALASSEMIA MAJOR PATIENTS AT A TERTIARY CARE HOSPITAL IN EGYPT

 

Mona Mohamed Hamdy Mahmoud

 315

SERUM YKL-40 LEVEL IN PATIENTS WITH B-THALASSEMIA : RELATION TO VIRAL HEPATITIS, LIVER STIFNESS AND HEPATIC IRON CONCENTRATION

Robbie Majzner

 2003

CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS*

Kelly Maloney

 2001

EXCELLENT EVENT-FREE (EFS) AND OVERALL SURVIVAL (OS) FOR CHILDREN WITH DOWN SYNDROME (DS) WITH STANDARD RISK B-ACUTE LYMPHOBLASTIC LEUKEMIA (SR B-ALL): RESULTS OF CHILDREN’S ONCOLOGY GROUP (COG) AALL0331*

Avani Mangoli

 010
MALIGNANT DISSEMINATED GLIONEURONAL TUMOR WITH BRAF-KIAA1549 FUSION AND 1p DELETION RESPONDS TO MEK-INHIBITOR: A CASE REPORT

 

Ross Mangum

 001

IDIOPATHIC HYPERAMMONEMIC ENCEPHALOPATHY: DIAGNOSTIC COMPLEXITIES AND MANAGEMENT OPTIONS

Jose Martinez

 656

PROPHYLACTIC PLATELET TRANSFUSIONS WITH A ≤ 10 X 109/L THRESHOLD DOES NOT RESULT IN A HIGHER INCIDENCE OF BLEEDING EPISODES IN PEDIATRIC PATIENTS UNDERGOING CHEMOTHERAPY: A COHORT STUDY.

Colleen Mathews

 073

VERY EARLY RELAPSE IN DS AML PATIENTS TREATED WITH A REDUCED DOSE ARA-C REGIMEN: A REPORT OF 2 CASES

Leonard Mattano

 715
OSTEONECROSIS IS ASSOCIATED WITH IMPROVED EVENT FREE (EFS) AND OVERALL SURVIVAL (OS) IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA (HR-ALL): RESULTS OF CHILDREN’S ONCOLOGY GROUP (COG) STUDY AALL0232

 

Lisa Maurer

 088

CONCURRENT LYME DISEASE SIGNIFICALLY IMPAIRS HEALING IN HEMOPHILIA HEMARTHROSIS

Jennifer Mayer

 442

WHY WE SHOULD TREAT HEMANGIOMA-ASSOCIATED HYPOTHYROIDISM WITH TRIIODOTHYRONINE (T3)

Peter McCarthy

 212

PREDICTORS OF RED BLOOD CELL TRANSFUSION, UNITS REQUIRED AND DONOR EXPOSURE IN LOW BIRTH WEIGHT INFANTS.

Sara McElroy

 812
COMPARING THE NEUROCOGNITIVE FUNCTION AMONG PATIENTS WITH PEDIATRIC BRAIN TUMORS TREATED WITH PROTON VERSUS PHOTON RADIATION THERAPY

 

Thomas McLean

 815

HYPOALBUMINEMIA IS NOT ASSOCIATED WITH INFERIOR SURVIVAL IN CHILDREN WITH CANCER

Jennifer McNeer

 705

POOR OUTCOME FOR CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH HYPODIPLOID ALL IS NOT IMPROVED BY HEMATOPOIETIC STEM CELL TRANSPLANT: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)

Casey Mehrhoff

 077

CLONE WARS: THE EMERGENCE OF A PHILADELPHIA-NEGATIVE CLONE IN A PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSE

Casey Mehrhoff

 062
CRITICALLY ILL 16-YEAR-OLD MALE WITH SEVERE IVIG-INDUCED COOMBS-POSITIVE HEMOLYTIC ANEMIA

 

Emily Meier

 320

VACCINATION STATUS IS NOT CORRELATED WITH MORTALITY IN ADULTS WITH SICKLE CELL DISEASE

Emily Meier

 603

A STEP ON THE PATH TO BUILDING A NOVEL TRANSITION PROGRAM: ONLINE LEARNING MODULES INCREASE FAMILY MEDICINE RESIDENTS' KNOWLEDGE ABOUT HYDROXYUREA AND COMPREHENSIVE CARE OF ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE BUT NOT TRANSITION BEST PRACTICES

Trevor Memmott

 630

APPLICATION OF KDIGO GUIDELINES IN ASSESSING AKI IN PEDIATRIC PATIENTS NEWLY DIAGNOSED WITH ALL

Laurel Metzler

 607
PROGNOSTIC GOALS OF CARE CONVERSATIONS FOR CRITICALLY ILL PEDIATRIC HEMATOLOGY/ONCOLOGY PATIENTS

 

Jennifer Michlitsch

 076

VINCRISTINE-INDUCED ANEMIA IN HEREDITARY SPHEROCYTOSIS

Jonathan Miller

 210

TWO CASES OF NEWLY DIAGNOSED MUSCULAR DYSTROPHY DISCOVERED IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA

Matthew Miller

 706

COMBINATION OF KRAS MUTATION AND TET2 LOSS LEADS TO MYELOID SKEWING AND SYNERGISTIC ACTIVATION OF RAS SIGNALING IN A NOVEL MURINE MODEL

Lane Miller

 724
INCIDENCE AND PREDICTORS OF RESPIRATORY ADVERSE EVENTS DURING INDUCTION THERAPY IN CHILDREN WITH ACUTE MYELOID LEUKEMIA

 

Katherine Minson

 720

BONE MARROW STROMAL CELL MEDIATED RESISTANCE TO MERTK INHIBITION IN AML

Nupur Mittal

 510

LOSS OF PROTECTIVE HUMORAL IMMUNITY AGAINST MEASLES IN PEDIATRIC ONCOLOGY PATIENTS: A RISK WITH THE RISE OF UNDERVACCINATION

Nupur Mittal

 765

SINGLE INSTITUTION EXPERIENCE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME ((PRES) ASSOCIATED WITH INDUCTION THERAPY FOR HIGH RISK PEDIATRIC ALL: IS
THERE A ROLE OF PHARMACOETHNICITY

Scott Moerdler

 219
DIFFERING PRENATAL HEMOGLOBINOPATHY SCREENING PRACTICES: HOW CAN THE PEDIATRIC HEMATOLOGIST INTERVENE?

 

Ashraf Mohamed

 733

YOUNG AGE IS HIGHLY ASSOCIATED WITH MORNING HYPOGLYCEMIA AMONG CHILDREN RECEIVING ALL THERAPY

Ashraf Mohamed

 767

PSYCHOSOCIAL AND PHYSICAL DISTRESS SCREENING: WHAT DO ADOLESCENTS AND YOUNG ADULTS ON CANCER THERAPY REPORT?

Ashraf Mohamed

 702

SERUM CREATININE SIGNIFICANTLY UNDERESTIMATED THERAPY RELATED CHRONIC KIDNEY DISEASES AMONG CHILDHOOD CANCER PATIENTS

Kathleen Montgomery

 663
PROSPECTIVE SYMPTOM ASSESSMENT IN CHILDREN WITH ADVANCED CANCER

 

Erin Morales

 045

RECURRENT UNRESECTABLE CONGENITAL PARASPINAL PRIMITIVE MYXOID MESENCHYMAL TUMOR OF INFANCY: A CASE REPORT AND REVIEW OF THE LITERATURE

Daniel Moreira

 631

REGIONAL IMPACT OF A PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWSHIP PROGRAM

Daniel Moreira

 633

CREATION OF A STANDARDIZED ASSESSMENT TOOL FOR GLOBAL PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWSHIP PROGRAMS

Amy Moskop

 112
EVANS SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS, AND NEUROFIBROMATOSIS: AN UNUSUAL COMBINATION IN PEDIATRIC PATIENT

 

Amy Moskop

 404

MECHANICAL HEMOLYSIS AND ACQUIRED TYPE 2A VONWILLEBRAND SYNDROME IN PATIENT WITH CONGENITAL HEART DISEASE

Michael Mowrer

 043

AN ALK FUSION NOT PREVIOUSLY REPORTED IN REFRACTORY NEUROBLASTOMA

Michael Mowrer

 766

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH HYPER IGE SYNDROME, PRESENTING TO THE PEDIATRIC INTENSIVE CARE UNIT WITH SEPSIS

Emily Mueller

 620
SURVEY OF MOBILE TECHNOLOGY USAGE AND PERCEPTIONS BY CAREGIVERS OF CHILDREN WITH CANCER

 

Nicole Muhlbauer

 015

SIGNIFICANT IMPROVEMENT IN PARANEOPLASTIC DYSAUTONOMIA WITH RITUXIMAB THERAPY

Jodi Muscal

 044

SUCCESSFUL TREATMENT OF SARCOMA ARISING WITHIN ANAPLASTIC WILMS TUMOR AND THERAPY-RELATED IRON OVERLOAD WITH PHLEBOTOMY

Kasiani Myers

 204

MDS AND AML IN SHWACHMAN DIAMOND SYNDROME: CLINICAL FEATURES AND OUTCOMES

Kalindi Narine

 337
VALIDITY AND FEASIBILITY OF USING A MOBILE APPLICATION AND WEARABLE TECHNOLOGY FOR PATIENTS WITH SICKLE CELL DISEASE HOSPITALIZED FOR PAIN

 

Hanan Nazir

 078

FRESH-FROZEN PLASMA TRANSFUSION FOR REPLACEMENT THERAPY IN A CHILD WITH HYPOPLASMINOGENEMIA AND LIGNEOUS CONJUNCTIVITIS: AN ALTERNATIVE OPTION TO
DELAY RECURRENCE

Hanan Nazir

 201

NEUTROPENIA AND LIFE THREATENING AGRANULOCYTOSIS AMONG CHILDREN WITH B THALASSEMIA TREATED WITH ORAL IRON CHELATORS IN A COMMUNITY WITH BACKGROUND OF ETHNIC NEUTROPENIA

Hanan Nazir

 220

HERMANSKY- PUDLAK SYNDROME: SPECTRUM IN OMAN

Stephen Nelson

 342
HYDROXYUREA USE IN INFANTS WITH SICKLE CELL DISEASE: THE EARLIER THE BETTER.

 

Adam Nelson

 903

BUILDING A THIRD-PARTY VST BANK FROM SCRATCH- THE CINCINNATI EXPERIENCE

Adam Nelson

 907

INCREASED CD34 CELL DOSE IS ASSOCIATED WITH RAPID IMMUNE RECONSTITUTION AFTER HSCT IN PATIENTS WITH FANCONI ANEMIA

Marie Laurence Noisette

 206

CLINICAL OUTCOME OF FETUSES AND NEWBORNS WITH ALLOIMMUNIZATION WHO RECEIVED INTRAUTERINE TRANSFUSION

Dolly Noun

 919
EARLY INFECTIOUS COMPLICATIONS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR HIGH-RISK NEUROBLASTOMA: HIGH IMPACT ON MORTALITY AND MORBIDITY

 

Jamie Oakley

 302

ACUTE KIDNEY INJURY DURING PARVOVIRUS B19-INDUCED TRANSIENT APLASTIC CRISIS IN SICKLE CELL DISEASE

Maureen O'Brien

 728

RESULTS OF A PHASE 2, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY OF LENALIDOMIDE IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Nancy Olivieri

 216

EVALUATION OF QUALITY OF LIFE IN SRI LANKAN PATIENTS WITH THALASSEMIA

Nancy Olivieri

 303
TWENTY-YEAR FOLLOW-UP OF PATIENTS WITH HEMOGLOBIN E THALASSEMIA IN SRI LANKA

 

Nancy Olivieri

 307

EXPERIENCE WITH THE IRON-CHELATOR DEFERASIROX IN SRI LANKAN PATIENTS WITH THALASSEMIA

Nancy Olivieri

 317

EVALUATION OF CLINICAL AND LABORATORY FINDINGS IN PATIENTS WITH HEMOGLOBIN E BETA THALASSEMIA IN A SINGLE CENTER IN KOLKATA, INDIA

Andrea Orsey

 610

USE OF AN INSTITUTIONAL-TREATMENT ALGORITHM TO IMPROVE THE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV)

Daniel Ortiz  355

PREVALENCE OF VITAMIN D DEFICIENCY AMONG CHILDREN AND YOUNG ADULTS WITH SICKLE CELL DISEASE AND ITS RELATIONSHIP WITH DISEASE SEVERITY

RebeccaOrtolano  084
NOVEL SAMD9L MUTATION IN A PATIENT WITH PANCYTOPENIA, IMMUNE DYSFUNCTION, AND MONOSOMY 7 MYELODYSPLASTIC SYNDROME
Christopher Ours  013
UNIQUE PRESENTATIONS OF ATAXIA-TELANGIECTASIA IN TWO BROTHERS
Joseph Oved  2010
OUTCOMES OF UNRELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION FOR PATIENTS WITH NON-MALIGNANT HEMATOLOGIC DISORDERS USING TWO PARTIAL T CELL DEPLETION STRATEGIES*
Holly Pacenta  713
IDENTIFICATION OF NOVEL THERAPEUTIC TARGETS IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA
Ruzanna Papyan  648
THE STATE OF PEDIATRIC ONCOLOGY IN ARMENIA: CHALLENGES AND ACHIEVEMENTS
Robin Parihar  2004
NATURAL KILLER CELLS TARGETING THE SUPPRESSIVE IMMUNE MICROENVIRONMENT OF PEDIATRIC SOLID TUMORS RESCUE THE IMPAIRED ACTIVITY OF CAR-T CELLS*
Priyal Patel  003
A RARE CASE OF IMMUNODEFICIENCY, CENTROMERE INSTABILITY, AND FACIAL ANOMALIES TYPE I SYNDROME IN A MALE INFANT
Krupesh Patel  011
WOLMAN DISEASE AND HLH, A CASE OF OVERLAPPING CLINICAL FEATURES
Krupesh Patel  109
A CASE FOR EARLY DABRAFENIB USE IN PATIENTS WITH BRAF V600E POSITIVE LOW GRADE GLIOMAS
Megan Paul  041
PRIMARY MULTIFOCAL INTRACEREBRAL EXTRAOSSEUS OSTEOSARCOMA WITH AGGRESSIVE CLINICAL COURSE IN A PATIENT WITH LOBAR HOLOPROSCENCEPHALY
Megan Paul  113
BONE METASTASES IN PEDIATRIC HIGH GRADE GLIOMA: A CASE SERIES AND REVIEW OF THE LITERATURE
Megan Paul  806
THE ROLE OF G-CSF RECEPTOR SURFACE EXPRESSION IN MEDULLOBLASTOMA PATHOGENESIS
Anjali Pawar  441
A PILOT STUDY OF SOCIAL AND ACADEMIC IMPLICATIONS OF HEAVY MENSTRUAL BLEEDING IN ADOLESCENT AND YOUNG ADULT FEMALES
Kimberly Payne  2023
NOVEL BIOLOGIC FOR THE TREATMENT OF PH-LIKE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH OVER EXPRESSION OF CRLF2*
Scott Penney  033
LONG TERM REMISSION WITH SIROLIMUS FOR A PEDIATRIC PATIENT WITH AN EBV-ASSOCIATED SMOOTH MUSCLE TUMOR AFTER BONE MARROW TRANSPLANTATION
Robin Pham  005
MUTATION OF CEP72 GENE MAY PREDISPOSE PATIENTS TO HEPATOTOXICITY
Rachel Phelan  642
A STANDARDIZED APPROACH USING PHLEBOTOMY TO TREAT TRANSFUSIONAL IRON OVERLOAD IN PEDIATRIC AND YOUNG ADULT ONCOLOGY PATIENTS
Lia Phillips  059
ALLOPURINOL USE WITH 6-MERCAPTOPURINE IN MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
Navin Pinto  820
PATTERNS OF EXPRESSION OF DISIALOGANGLIOSIDE GD2 IN PEDIATRIC SARCOMAS
Lauren Pommert  101
PRIMARY EXTRARENAL WILMS TUMOR OF THE TESTIS
Samara Potter  012
PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Jacquelyn Powers  2011
CAREGIVER PERCEPTIONS OF IRON DEFICIENCY ANEMIA AND IRON REPLACEMENT THERAPIES IN YOUNG CHILDREN WITH NUTRITIONAL IRON DEFICIENCY ANEMIA*
Pinki Prasad  609
MONOCLONAL ANTIBODY UTILIZATION IN ADOLESCENTS AND YOUNG ADULTS: A POPULATION BASED STUDY
Suraj Pratap  712
GENERATION AND CHARACTERIZATION OF FLT3 LIGAND-CONTAINING CHIMERIC ANTIGEN RECEPTOR (CAR) T-LYMPHOCYTES
Zachary Prudowsky  514
ASSESSING RISK OF HOSPITAL-ACQUIRED PEDIATRIC VENOUS THROMBOEMBOLISM USING A NOVEL SCORING SYSTEM
Geetha Puthenveetil  436
MULTIDISCIPLINARY APPROACH TO TREATMENT OF VASCULAR MALFORMATIONS - A SINGLE INSTITUTION EXPERIENCE
Charles Quinn  2009
NEUROPROTECTIVE EFFECTS OF HYDROXYUREA IN SICKLE CELL ANEMIA: MAINTENANCE OF NORMAL CEREBRAL OXYGENATION*
Charles Quinn  319
EARLY INITIATION OF DISEASE-MODIFYING THERAPY PREVENTS DIFFUSE MYOCARDIAL FIBROSIS IN SICKLE CELL ANEMIA
Venkatraman Radhakrishnan  508
EFFICACY OF SINGLE DOSE RASBURICASE (1.5 MG) FOR PROPHYLAXIS AND MANAGEMENT OF TUMOR LYSIS SYNDROME
Elizabeth Raetz  725
CONTINUED IMPROVEMENTS IN OVERALL SURVIVAL (OS) IN CHILDREN WITH NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A CHILDREN’S ONCOLOGY GROUP (COG) REPORT
Saman Raftari  730
FREQUENCY OF 17P ABNORMALITIES IN IRANIAN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) .
Nora Rahmani  768
SINUS HISTIOCYTOSIS WITH MASSIVE LYMPHADENOPATHY: CASE SERIES AND LITERATURE REVIEW TO HIGHLIGHT TREATMENT OPTIONS
Sandhya Rajan  606
METABOLIC SYNDROME IN CHILDHOOD CANCER SURVIVORS IN SOUTH INDIA
Archana Ramgopal  405
CENTRAL LINE-RELATED DEEP VEIN THROMBI IN CHILDREN: A CLEVELAND CLINIC EXPERIENCE
Lauren Raney  507
KNOWLEDGE OF AND ATTITUDES TOWARDS HPV VACCINE IN PREADOLESCENTS AND TEENS
Andrew Rankin  801
LANDSCAPE OF TARGETABLE BRAF ALTERATIONS AND RAF1 FUSIONS IN PEDIATRIC MALIGNANCY
Wafaa Rashed  660
SECOND TUMOR IN THYROID CANCER PEDIATRIC SURVIVORS
Scott Raskin  823
AN UNUSUAL CASE PRESENTATION OF A SEX CORD STROMAL TUMOR IN A 3 MONTH OLD INFANT
Yaddanapudi Ravindranath  410
MANAGEMENT OF BUDD CHIARI SYNDROME IN CHILDREN
Kiranmye Reddy  098
17 YEAR OLD FEMALE WITH POLYCYTHEMIA SECONDARY TO A HIGH OXYGEN AFFINITY HEMOGLOBINOPATHY
Ariel Reinish  312
ADDRESSING THE EDUCATIONAL NEEDS OF ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE AS THEY TRANSITION TO THE ADULT HEALTHCARE SYSTEM: A PILOT STUDY
Allison Remiker  2025
MECHANISMS LINKING FIBRIN(OGEN) STRUCTURE/FUNCTION TO TUMOR METASTASIS*
Allison Remiker  072
SUCCESSFUL TREATMENT WITH MYCOPHENOLATE MOFETIL IN SEVERE HEMOPHILIA A COMPLICATED BY HIGH TITER INHIBITOR: A CASE REPORT
Jennifer Rohan  759
ELECTRONIC MONITORING OF MEDICATION ADHERENCE DURING MAINTENANCE PHASE THERAPY FOR PEDIATRIC CANCER: BEHAVIORAL ADHERENCE PATTERNS
Jenna Rossoff  617
COST ANALYSIS OF BRONCHOALVEOLAR LAVAGE AND RESPIRATORY TRACT BIOPSIES IN THE DIAGNOSIS AND MANAGEMENT OF SUSPECTED INVASIVE FUNGAL INFECTION
Seth Rotz  757
LONG-TERM OUTCOMES IN PEDIATRIC HEART TRANSPLANTATION RECIPIENTS WITH SECONDARY MALIGNANCY: A SINGLE INSTITUTION STUDY
Seth Rotz  909
SCREENING ECHOCARDIOGRAPH MAY NOT BE NECESSARY IN A SUBSET OF LONG-TERM SURVIVORS OF PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Jennifer Ruiz  055
ACUTE LYMPHOBLASTIC LEUKEMIA IN PEDIATRIC GM1 GANGLIOSIDE TYPE 1
Melisa Ruiz-Gutierrez  2002
INDUCED PLURIPOTENT STEM CELL MODEL OF 7Q DELETION IN BONE MARROW FAILURE IDENTIFIES A NOVEL THERAPEUTIC STRATEGY*
Daniel Runco  655
IMPACT OF TUMOR TYPE AND TREATMENT INTENSITY ON WEIGHT-FOR-AGE THROUGH CANCER THERAPY IN CHILDREN LESS THAN 3 YEARS OLD
Katherine Ryan  064
A RARE CASE OF PRIMARY POLYCYTHEMIA VERA IN A PEDIATRIC PATIENT
Anthony Sabulski  714
A PEDIATRIC LEUKEMIA PATIENT-DERIVED XENOGRAFT SYSTEM FOR PRE-CLINICAL TESTING OF THERAPEUTIC TARGETS IDENTIFIED BY NEXT-GENERATION SEQUENCING
Yasim Saied  100
A CONDITION OF MULTIPLE ORIFICE BLEEDING IN ABSENCE OF COAGULATION OR PLATELETS DEFECTS.
Gabriel Salinas Cisneros  763
OUTCOMES AND CHOICES OF PLACEMENT OF CENTRAL VENOUS ACCESS IN PATIENTS WITH A NEW DIAGNOSIS OF LEUKEMIA
Pranav Santapuram  616
HEALTH OUTCOMES IN CONTEMPORARY SURVIVORS OF PEDIATRIC HODGKIN LYMPHOMA
Amanda Saraf  612
EXAMINING PREDICTORS AND OUTCOMES OF FERTILITY CONSULTS AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH CANCER
Alexandra Satty  917
THE ROLE OF TONSILLECTOMY IN PATIENTS WITH LOCALIZED EPSTEIN-BARR VIRUS-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Kay Saving  308
QUALITY IMPROVEMENT FOR UREA ADHERENCE IN KIDS WITH SICKLE CELL DISEASE (QUAKS)
Kay Saving  348
ADVANTAGES OF USING QUALITY IMPROVEMENT (QI) PROCESSES TO IMPROVE THE CARE OF A SICKLE CELL POPULATION
Matthew Schefft  318
IMPACT OF PCR-BASED VIRAL PANELS ON CARE FOR FEBRILE CHILDREN WITH SICKLE CELL DISEASE
Lauren Scherer  356
A CASE OF SEVERE EBV VIREMIA PRESENTING WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH UNDIAGNOSED SICKLE CELL ANEMIA
Deborah Schiff  085
SUCCESSFUL TREATMENT WITH BORTEZOMIB, PANOBINOSTAT, AND DEXAMETHASONE OF ACUTE MYELOID LEUKEMIA (AML) IN 2ND RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) : THERAPY SELECTED BASED UPON RESULTS OF A PERSONALIZED FLOW CYTOMETRIC SCREEN FOR DRUG SENSITIVITY
Wade Schulz  433
TRANSFUSION OF PATHOGEN-REDUCED (PR) SINGLE DONOR PLATELETS (SDP) TO THROMBOCYTOPENIC NEONATES AND PEDIATRIC PATIENTS: EVALUATION OF PLATELET USAGE AND TRANSFUSION REACTIONS (TR)
Jessica Seaborn  513
IMPROVING HOSPITAL PRACTICES FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH EARLY PROPHYLACTIC USE OF OLANZAPINE IN CHILDREN WITH CANCER
Laura Sedig  622
BEREAVED PARENT PERSPECTIVES ON END OF LIFE CARE FOR PEDIATRIC ONCOLOGY PATIENTS
Catherine Segbefia  312
PUBERTAL CHANGES IN CHILDREN WITH SICKLE CELL DISEASE AT KORLE BU TEACHING HOSPITAL, ACCRA, GHANA
Tyler Severance  912
GRANULOCYTE TRANSFUSIONS IN PEDIATRIC PATIENTS WITH NEUTROPENIA: ASSESSING EFFICACY AND OUTCOMES FOLLOWING THE USE OF A LOCAL GRANULOCYTE DONOR PROGRAM
Nidhi Shah  068
DIFFERENTIATING ATYPICAL HEMOLYTIC UREMIC SYNDROME VERSUS AUTOIMMUNE HEMOLYTIC ANEMIA: MANAGEMENT OF PATIENTS IN EXTREMIS
Sanam Shahid  037
IATROGENIC IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN A CHILD WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Mark Shamoun  089
LONG TERM REMISSION WITH TOPOTECAN, VINORELBINE, THIOTEPA, AND CLOFARABINE (TVTC) FOR RE-INDUCTION FOLLOWED BY MAINTENANCE THERAPY WITH VENETOCLAX IN A YOUNG ADULT PATIENT WITH AML THAT RELAPSED POST TRANSPLANT.
Margaret Shatara  701
HEMOGLOBIN AND PLATELET THRESHOLDS FOR RED BLOOD CEEL AND PLATELET TRANSFUSIONS IN CHILDREN UNDERGOING TREATMENT FOR ONCOLOGIC DISEASES
Jenny Shim  831
TARGETING THE YES-ASSOCIATED PROTEIN IN NEUROBLASTOMA
Giselle Sholler  805
A BEAT CHILDHOOD CANCER PILOT STUDY FOR HIGH RISK NEUROBLASTOMA AT DIAGNOSIS WITH MOLECULAR GUIDED THERAPY AND EXTENDED MAINTENANCE WITH DFMO
Iman Sidhom  723
IMPACT OF MINIMAL RESIDUAL DISEASE ON OUTCOME OF CHILDREN WITH HYPODIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA
David Siegel  605
INCIDENCE RATES AND TRENDS OF PEDIATRIC CANCER — UNITED STATES, 2001–2014
Debra Simon  049
METASTATIC NEUROENDOCRINE CARCINOMA RESPONDING TO MEK INHIBITION
Luke Smart  335
GEOSPATIAL MAPPING OF SICKLE CELL DISEASE IN NORTHWESTERN TANZANIA
Valeria Smith  017
EXPLORING WHY PEDIATRIC CANCER PATIENTS ARE DYING IN THE INTENSIVE CARE UNIT WITH LONGSTANDING DO NOT RESUSCITATE ORDERS
Valeria Smith  035
EXPLORING WHY PEDIATRIC CANCER PATIENTS ARE DYING IN THE INTENSIVE CARE UNIT WITH LONGSTANDING DO NOT RESUSCITATE ORDERS
Christine Smith  218
THROMBOCYTOPENIA IN THE SETTING OF MENORRHAGIA-INDUCED IRON DEFICIENCY ANEMIA: A SERIES OF THREE CASES
Christine Smith  634
ADAPTATION OF CANCER CENTER SURVIVORSHIP CARE PLAN GUIDELINES IN THE PEDIATRIC ONCOLOGY POPULATION
Wesley Smith  719
EVALUATION OF CHEST X-RAYS AND THE ASSOCIATED CLINICAL COURSE FOR CHILDREN WITH NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA
Jennifer Snaman  522
INCORPORATING BEREAVED PARENTS AS FACULTY FACILITATORS AND EDUCATORS IN TEACHING PRINCIPLES OF PALLIATIVE AND END-OF-LIFE CARE TO ONCOLOGY PROVIDERS
Jennifer Snaman  627
COMMUNICATION TRAINING EXPERIENCE AND NEEDS ASSESSMENT FOR FELLOWS IN PEDIATRIC HEMATOLOGY-ONCOLOGY
Stacy Snyder  019
ATAXIA TELANGIECTASIA PRESENTING WITH SEVERE NEUTROPENIA AND INVASIVE ACTINOMYCES INFECTION.
Amy Sobota  304
SCREENING FOR SOCIAL DETERMINANTS OF HEALTH IN AN URBAN PEDIATRIC SICKLE CELL DISEASE CLINIC: A QUALITY IMPROVEMENT INITIATIVE
Amy Sobota  306
DISPENSING LIQUID HYDROXYUREA TO PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A NOVEL INSTITUTIONAL APPROACH TO REDUCING BARRIERS TO ADHERANCE
Elizabeth Sokol  837
PROGNOSTIC SIGNIFICANCE OF METASTATIC MIBG-POSITIVE DISEASE SITES AT DIAGNOSIS IN HIGH-RISK NEUROBLASTOMA PATIENTS
Heather Soni  408
INTERNATIONAL NORMALIZED RATIO (INR) DOCUMENTATION OPTIMIZATION: A CLINICAL AND INFORMATICS COLLABORATIVE APPROACH
Caryn Sorge  093
COMMON VIRUS OR RETURN OF MALIGNANCY? ADENOVIRUS IN A PATIENT WITH BURKITT LYMPHOMA
Emily Southard  213
THE EMERGING ROLE OF MECOM MUTATIONS IN PEDIATRIC BONE MARROW FAILURE: A CASE SERIES
Philippa Sprinz  314
THE CLINICAL COURSE OF CHILDREN AND YOUNG ADULTS WITH SICKLE CELL DISEASE IN NORTHERN HAITI TREATED WITH PENICILLIN AND HYDROXYUREA
Meera Srikanthan  018
A CASE OF RUBINSTEIN-TAYBI SYNDROME PRESENTING WITH NEUROBLASTOMA AND MALIGNANT HYPERTENSION
Anand Srinivasan  069
IDH1 MUTATED ACUTE MYELOID LEUKEMIA IN A CHILD WITH METAPHYSEAL CHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA
Anand Srinivasan  083
MYELOID NEOPLASMS ASSOCIATED WITH EOSINOPHILIA: A RARE PEDIATRIC ENTITY
David Stammers  434
A FIBRO-ADIPOSE VASCULAR ANOMALY MASQUERADING AS AN INTRAMUSCULAR HEMATOMA IN THE SETTING OF IMMUNE THROMBOCYTOPENIA
Claire Stokes  521
REDUCING LENGTH OF STAY OF HIGH-DOSE METHOTREXATE ADMISSIONS
Brian Stover  810
PERSONALIZED RNA-NANOPARTICLE VACCINES TARGETING OSTEOSARCOMA
Austin Stuckert  721
USE OF ALLOPURINOL TO REDIRECT 6-MERCAPTOPURINE METABOLISM IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Jacqueline Sun  417
COMPARISON OF BODY MASS INDEX AND JOINT HEALTH OUTCOMES IN PEDIATRIC HEMOPHILIA A PATIENTS
Neeraja Swaminathan  030
MUCOEPIDERMOID CARCINOMA: CASE REPORT AND ANALYSIS OF MECT1-MAML2 FUSION TRANSCRIPT IN CASES FROM IOWA
Takuto Takahashi  345
RISK FACTORS FOR RESPIRATORY FAILURE AMONG PEDIATRIC ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE
Ravi Talati  668
CAN PICC LINE ASSOCIATED VENOUSTHROMBOEMBOLISM BE PREVENTED BY EARLY REMOVAL?
David Taylor  407
LACK OF CORRELATION BETWEEN BLEEDING SCORES AND PLATELET ELECTRON MICROSCOPY IN DELTA-GRANULE STORAGE POOL DISORDER
Aravind Thavamani  347
MEAN PLATELET VOLUME IN SICKLE CELL DISEASE PREDICTS MORTALITY AND DISEASE SEVERITY
Lincy Thomas  042
DIFFUSE MIDLINE GLIOMA, H3K27M-MUTANT TUMOR WITH IMMUNOHISTOCHEMISTRY DIFFUSELY POSITIVE FOR SYNAPTOPHYSIN AND NEGATIVE FOR GFAP
William Thomsen  022
DESCRIPTION OF A NOVEL BRAF MUTATION IN CHILD WITH FIBROUS HAMARTOMA OF INFANCY
Karen Thudium Mueller  707
IMPACT OF HUMORAL IMMUNOGENICITY (ANTI-MCAR19 ANTIBODIES) ON TISAGENLECLEUCEL (CTL019) CELLULAR KINETICS, EFFICACY, AND SAFETY
Margaret Tonda  301
INITIAL RESULTS FROM A COHORT IN A PHASE 2A STUDY (GBT440-007) EVALUATING ADOLESCENTS WITH SICKLE CELL DISEASE TREATED WITH MULTIPLE DOSES OF VOXELOTOR, A SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR
Margaret Tonda  352
NOVEL TRIAL DESIGN TO EVALUATE ORAL VOXELOTOR FOR THE TREATMENT OF SICKLE CELL DISEASE: PROTOCOL OF THE PHASE 3 HEMOGLOBIN OXYGEN AFFINITY MODULATION TO INHIBIT SICKLE HEMOGLOBIN POLYMERIZATION (HOPE) TRIAL (GBT440-031)
Carlos Torres  628
'THEY HELP WEAVE IT ALL TOGETHER': STAFF IMPACT ON BEREAVED PARENTS' GRIEF AFTER THEIR CHILD DIES OF CANCER
Adriana Trabal  027
SINUSOIDAL OBSTRUCTION SYNDROME AND SUSCEPTIBILITY TO BLEEDING AFTER GASTRIC TUBE PLACEMENT
Adriana Traba  103
TRABECTEDIN RESPONSE IN REFRACTORY METASTATIC SYNOVIAL SARCOMA
Cameron Trenor  2026
SAFETY AND PATIENT-REPORTED EFFICACY OF SIROLIMUS IN 120 PATIENTS WITH VASCULAR ANOMALIES: A REPORT FROM THE LYMPHATIC ANOMALIES REGISTRY*
Cameron Trenor  426
SIROLIMUS FOR REFRACTORY FIBROADIPOSE VASCULAR ANOMALY
Erin Trovillion  905
RESTORATION OF CD4+FOXP3+ REGULATORY T CELLS AND PROTECTION FROM CHRONIC GRAFT VERSUS HOST DISEASE IN PEDIATRIC TRANSPLANT PATIENTS DEPENDS ON EFFECTIVE POST-TRANSPLANT THYMOPOIESIS
Luci Turcotte  065
SYNCHRONOUS HEMATOLOGIC MALIGNANCIES: CONCURRENT SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA AND B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A PEDIATRIC PATIENT
Elizabeth Ulm  756
DISEASE-CAUSING COPY NUMBER VARIANTS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS DISEASE GENES
Ramya Uppuluri  906
HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE IN BENIGN HEMATOLOGICAL DISORDERS – COST EFFECTIVE CURE FOR CHILDREN IN INDIA
Sarah R. Vaiselbuh  743
EXOSOMAL MICRO RNA-181a INHIBITION CURBS LEUKEMIC PROLIFERATION IN PEDIATRIC ALL.
Kristen VanHeyst  836
TARGETING VCAM-1/α4β1 SIGNALING TO AMELIORATE PULMONARY METASTATIC OSTEOSARCOMA
Liliana Vasquez  632
FACTORS ASSOCIATED WITH ABANDONMENT OF PEDIATRIC CANCER TREATMENT IN PERU: A MULTICENTER COHORT STUDY
Jacqueline Vaughn  910
FEASIBILITY AND ACCEPTABILITY OF USING A MOBILE APP AND WEARABLE FOR PATIENTS UNDERGOING PEDIATRIC BLOOD AND MARROW TRANSPLANT
Saranya Veluswamy  327
COLD PAIN CAUSES GREATER VASOCONSTRICTION IN SICKLE CELL DISEASE SUBJECTS AND NORMAL CONTROLS EXPOSED TO GRADED THERMAL STIMULI
Rajkumar Venkatramani  834
UTILITY OF GALLIUM 68 DOTATATE PET/CT SCAN IN PEDIATRIC NEUROENDOCRINE TUMORS: A REPORT FROM TEXAS CHILDREN’S RARE TUMOR REGISTRY
Gabriela Villanueva  741
A STUDY OF THE ASSOCIATION BETWEEN CYTOGENETICS, RACE AND ETHNICITY AMONG PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AT THE UNIVERSITY OF CHICAGO
Shelton Viola  710
A NOVEL METHOD OF ISOLATING PRIMARY BONE MARROW MESENCHYMAL STEM AND STROMAL CELLS IN LEUKEMIA
Cielle Wachnian  359
COLD EXTERNAL TEMPERATURES AND SICKLE CELL MORBIDITY IN CHILDREN: A RETROSPECTIVE ANALYSIS
Yuexi Wang  322
CLINICAL BURDEN AND MANAGEMENT OF SICKLE CELL DISEASE AMONG PEDIATRIC PATIENTS
Russell Ware  323
NOVEL USE OF HYDROXYUREA IN AN AFRICAN REGION WITH MALARIA (NOHARM): YEAR 2 FINAL RESULTS
Russell Ware  325
NOVEL USE OF HYDROXYUREA IN AN AFRICAN REGION WITH MALARIA: EFFECTS OF HYDROXYUREA TREATMENT ON TRANSCRANIAL DOPPLER (TCD) VELOCITIES
Russell Ware  349
STROKE AVOIDANCE FOR CHILDREN IN REPUBLICA DOMINICANA (SACRED)
Carla Washington  305
THE PHARMACOKINETICS OF VOXELOTOR FOLLOWING SINGLE DOSES IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
Jennifer Webb  518
QUALITY IMPROVEMENT: TEXT-BASED APPOINTMENT REMINDERS FAIL TO IMPROVE RATES OF MISSED TRANSFUSION APPOINTMENTS
Mary Frances Wedekind  838
INCREASED ANTITUMOR EFFICACY OF PD-1 BLOCKADE COMBINED WITH ONCOLYTIC HERPES VIROTHERAPY IN MURINE OSTEOSARCOMA IS DUE TO INCREASED CD8+/TREG RATIO
Rebecca Weicht  840
POLYAMINE BIOSYNTHETIC PATHWAY AS A DRUG TARGET FOR OSTEOSARCOMA THERAPY
Julie Weisman  2027
PERIPHERAL ARTERIAL THROMBOSIS IN HOSPITALIZED CHILDREN: CHARACTERISTICS AND SHORT-TERM OUTCOMES OF EXTENDED ANTICOAGULATION*
Laura Wheaton  734
PREGNANCY TESTING AND CONTRACEPTIVE COUNSELING IN FEMALES WITH NEWLY DIAGNOSED HODGKIN LYMPHOMA: EXPERIENCE AT A PEDIATRIC CENTER
Shanna White  726
CHEST X-RAY FINDINGS IN NEWLY DIAGNOSED PEDIATRIC ACUTE MYELOID LEUKEMIA
Andrea Whitfield  094
A CHALLENGING CASE OF HEPARIN INDUCED THROMBOCYTOPENIA IN A CRITICALLY ILL PEDIATRIC PATIENT AND NEED FOR ALTERNATIVE ANTI-COAGULATION
Brittney Whitford  517
HELPING OUR PEERS ENDURE STRESS (HOPES) – A PEER SUPPORT INITIATIVE IN PEDIATRIC HEMATOLOGY / ONCOLOGY
Sarah Whittle  647
PEDIATRIC CANCER HOSPITALIZATIONS PAID FOR BY MEDICAID ARE LONGER THAN THOSE PAID FOR BY COMMERCIAL INSURANCE
Hope Wilson  411
UTILITY OF PLATELET AGGREGATION TESTING AS A DIAGNOSTIC TOOL IN PEDIATRIC PATIENTS WITH BLEEDING PROBLEMS
Katrina Winsnes  615
DELIRIUM: A PROSPECTIVE STUDY WITHIN THE PEDIATRIC HEMATOLOGY, ONCOLOGY, AND BONE MARROW TRANSPLANT (PHO) POPULATION AT A SINGLE INSTITUTION
Nicole Wood  509
STANDARDIZING MEDICATION RECONCILIATION FOR A SAFE AND SUCCESSFUL DISCHARGE HOME IN NEWLY DIAGNOSED PEDIATRIC ONCOLOGY PATIENTS
Erin Wright  106
MANAGEMENT OF BLEEDING IN A PATIENT WITH JUVENILE DERMATOMYOSITIS AND UNRESPONSIVE IMMUNE THROMBOCYTOPENIA
Erin Wright  904
SUCCESSFUL USE OF BASILIXIMAB IN THE TREATMENT OF STEROID REFRACTORY GRAFT VERSUS HOST DISEASE IN A TWO YEAR OLD FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANT
Natalie Wu  524
OUTCOMES OF OBSERVATION WITHOUT EMPIRIC IV ANTIBIOTICS IN FEBRILE, NON-NEUTROPENIC PEDIATRIC ONCOLOGY PATIENTS
Jade Wulff  828
TARGETING INTEGRIN-MEDIATED SIGNALING IN METASTATIC EWING SARCOMA
Nathan Yarnall  731
HEPATOTOXICITY REQUIRING LIVER BIOPSY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
David Young  2024
UNIVERSAL PRETREATMENT FOR ASPARAGINASE-BASED THERAPY SHOULD BE STANDARD OF CARE*
Lindsey Young  502
CHEMOTHERAPY INDUCED NAUSEA VOMITING: NURSING ASSESSMENT AND UTILITY OF THE BAXTER RETCHING FACES (BARF) NAUSEA SCALE
Ahmar Zaidi  331
IDENTIFYING AND ASSESSING AT-HOME VASO-OCCLUSIVE CRISES (VOC) IN PATIENTS WITH SICKLE CELL DISEASE (SCD) LONGITUDINALLY USING ELECTRONIC PATIENT-REPORTED OUTCOMES (PRO), ACTIGRAPHY AND BIOMARKERS (ELIPSIS)
Sara Zarnegar  662
REPPAIR TRIAL: REDUCING PROCEDURAL PAIN AND IMPROVING RECOVERY OF QUALITY OF LIFE IN PEDIATRIC NEUROBLASTOMA PATIENTS UNDERGOING BONE MARROW PROCEDURES, A PROSPECTIVE, RANDOMIZED, CROSS-OVER CLINICAL TRIAL
Jessica Zimmerman  039
TWO CASES OF EBF1-PDGFRB FUSION B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH SIMILAR CLINICAL PRESENTATIONS AND TREATMENT BUT DIFFERENT OUTCOMES AT THE UNIVERSITY OF IOWA
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
  • Schedule of Events
  • Accepted Papers and Posters
Advertising, Exhibits, & Support | Career Center | Calendar | Contact Us
Terms of Use & Privacy Policy » © The American Society of Pediatric Hematology/Oncology